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CHAPTER I 
INTRODUCTION 
Interest in problems concerning impaired fertility in the bull has 
stennned from the development of artificial insemination programs where a 
single ejaculate may be used to inseminate many cows. Frequently a good, 
proven bull may experience temporary infertility due to age, season of 
year, or endocrine imbalance. One possible approach to the treatment of 
infertility is through the use of hormonal therapy. One such attempt to 
improve fertility in humans and certain laboratory animals is by means of 
the "rebound phenomenon". This phenomenon is brought about through injec-
tions of testosterone which temporarily blocks the spermatogenic processes. 
Some time after injections have been stopped, the animal goes through a 
period of increased spermatozoa numbers with a corresponding increase in 
fertility. The mechanism for the depression of spermatogenesis is now 
thought to be through the control of pituitary gonadotrophins which in 
turn control spermatogenic processes. Pituitary gonadotrophins influence 
Leydig cells to produce testosterone, the male sex hormone. Testosterone 
in turn is respons ible for development of the male sex characteristics, 
stimulation of germinal epithelium favoring sperma.togenesis, and suppres-
sion of gonadotrophin production by the pituitary . Therefore, this 
experiment was designed to test this phenomenon in normal bulls to see i f 
it could be applied later t o abnormal bul ls. 
The experiment was conduc ted in two parts. The first part was 
designed to evaluate spermatogeni c and testicular function. These data 
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have been reported by Meinecke (75) and Meinecke and McDonald (76). The 
second part consisted of following the overall metabolism of steroids 
during the experiment and the correlation of these data with the reproduc-
tive data from the first part of the experiment. These data were 
collected to see if the clinician and researcher could follow reproductive 
processes in the bull during the rebound phenomenon using chemical tests 
instead of purely histological and gross anatomical observations. Since 
very little is known concerning the metabolism of testosterone in the bull 
and how it affects other steroids and their metabolism, one of the prime 
objectives was to gain information as to how the ruminant metabolizes and 
excretes steroidal material. The results of these experiments form the 
first part of the thesis. 
Several questions arose during the above studies in connection with 
the mode of conjugation and metabolism of steroids and carotenoid compounds 
from the diet, henceforth referred to as ionone derivatives. Therefore, 
research was undertaken to evaluate several probable sites of conjugation 
in addition to evaluating some factors influencing conjugation of steroids 
in these animals. In the process of working out methods for evaluating the 
foregoing problems, additional studies were undertaken in the dog and rat. 
The data collected from these animals have made possible certain pertinent 
comparisons with similar data collected from sheep. The results of these 
experiments form the second part of the thesis. 
CHAPTER II 
REVIEW OF LITERATURE 
Effects of Steroids on Spermatogenesis 
Prolonged administration of exogenous testosterone has been shown to 
inhibit spermatogenesis in man and rat (12, 47, 48, 71, 112, 132); how-
ever, degeneration of the testes was more pronounced following smaller 
doses than from larger doses of this steroid (49, 71, 146). Studies of 
a similar nature had not been reported in the bull until Meinecke and 
McDonald reported their findings from this joint investigation. However, 
Holtz (57) has reported briefly on the urinary excretion of steroids 
following intramuscular injections of testosterone propionate in oil to 
a bull, steer, and cow. Slow absorption of testosterone from the injec-
tion site into the blood was assumed since the urine, collected three 
months later, contained marked amounts of etiocholanolone, which is 
considered to be a testosterone metabolite. 
Intramuscular injections of 500 mg . of cortisone tri-weekly for 12 
weeks has been reported to increase the sperm count and the fructose levels 
in the semen from a normal bull (19). Injections of cortisone and hydro-
cortisone have been reported to increase the number and decrease the 
percentage of abnormal forms of spermatozoa of two bulls with poor semen 
quality (18) . Hydrocortisone was effective at a lower level than corti-
sone. Deoxycorticosterone acetate had no measurable effect on semen 
quality of one bull. Of six bulls treated with testosterone, only one 
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responded with an increased libido and a rise in seminal fructose. 
Motility of the spermatozoa was not altered by any of the hormones studied. 
Measurements of Urinary Steroids 
Considerable work in the area of ste~oid metabolism has been accom-
plished in humans but relatively little work has been done in dairy 
cattle (84), especially in bulls. 
The isolation of pregnanediol-3(a)-20(a), allo-pregnanediol-3(a)-
20(a), allo-pregnanediol-3(b)-20(a), alpha and beta equistanol, andros-
terone, and dehydroandrosterone from urine of pregnant cow's urine was 
accomplished by Marker (73, 74). 
The so-called neutral steroid fraction of cattle and horse urine was 
investigated photometrically by Meschanks (77) using the Zinnnerman and 
Pincus reactions. Although variations in steroid content were noticed 
with respect to specific gravity, diurnal variation, and certain metabolic 
states of the animal, the absorption curves of the colors produced by 
these reactions did not correspond with androsterone or other typical 
17-ketosteroids. 
The use of zinc and HCl for the hydrolysis of cow urine prior to 
extraction of 17-ketosteroids was reported by Arrhenius (2); however, no 
data were reported to establish the steroid nature of the extracts. 
Gassner et al. (36) isolated a steroid fraction from venous blood of 
cows following intravenous injections of ACTH. This fraction was char-
acterized by a positive androgenic bioassay and a positive Zimmerman 
reaction for 17-ketosteroids. 
Preliminary work on the extraction, separation, and spectrophotometric 
analysis of the neutral steroid fractions of cow urine was reported by 
5 
Mixner (80) and Mixner and Saunders (82, 83). Although definite absorp-
tion spectra were obtained with the Zimmerman, Pincus, and Allen color 
reactions, these spectra did not correspond to those obtained with the 
17-ketosteriods in man. 
Holtz (56) noticed the presence of several ionone derivatives in 
extracts of cow urine which were identified as (2,3,6-trimethyl-benzol)-
acetone, 5-hydroxy-cis-tetrahydro-ionone, and 5-oxo-cis-tetrahydro-ionol; 
other ionone derivatives were not definitely established. When introduced 
into the Zimmerman reaction, some of these compounds gave absorption curves 
similar to those reported by Meschanks (77) and Mixner (80) for their crude 
extracts which undoubtably contained these ionone derivatives. A blue-
violet color with an absorption maximum at 550 mu was obtained with 
5-hydroxy-cis-tetrahydro-ionone and the Pincus reagent as previously 
reported (77, 80) for urine extracts. Dehydroisoandrosterone, etiocholano-
lone and 11-hydroxyandrosterone were also demonstrated as 17-ketosteroids. 
The ionone derivatives were attributed to the carotenoid derivatives from 
animal feed rich in carotene. 
Others have reported on the fractionation of steroids and their 
determination (53, 55, 113) without establishing the steroid nature of 
the various fractions. 
Mixner et al. (84),using column chromatography and infra red spectrwn 
~ ~
analyse~ found that the ionone derivatives were present in the conjugated 
form in urine and that they may be hydrolyzed by either acids or 
~-glucuronidase . Following hydrolysis, the ionone derivatives and steriods 
were extractable with lipid solvents. Specific absorption spectra were 
obtained with these chromogens us i ng Zimmerman, Pincus, and Allen color 
reactions. The spectra differed from that of the true 17-ketosteroids. 
At least six chromogens were found which reacted similarly to 17-keto-
steroids on alumina chromotographic columns. Distinct diurnal rhythms 
were found in the urinary excretion pattern of steroids from these 
animals. 
Holtz (57) analyzed urine of cattle following acid hydrolysis and 
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isolation of the neutral steriod fractions. Purification and separation 
were accomplished using Girard's reagent T and column and paper chromoto-
graphy. The main compounds isolated from the neutral lipid fraction of 
cattle urine were recognized as the ionone derivatives which were first 
obtained from pregnant mares' urine by Prelog et al. (see reference 57). 
Those identified by use of paper chromatography were: (2,3,6-trimethyl-
benzo l)-acetone (ketone J), 5-hydroxy-cis-tetrahydro-ionone (hydroxyketone 
G), and 5-oxo-cis-tetrahydro-ionol (hydroxyketone E). Two other spots 
were due probably to 5-oxo-cis-tetrahydro-ionone (diketone D), 2,2,8-
trimethyl-bicyclo-/C>,0,4/-dekadien-5,7-one-4 (ketone K), the bicyclic 
- -
hydroxyketone C of unknown structure, or a mixture of these compounds. 
All of these substances react with the Zimmerman reagents. Ketone J gave 
a spectrum almost identical with that of typical 17-ketosteroids. It was 
estimated that 90 per cent of the total ketosteroid content of urine was 
due to these non-steroidal substances. The maximal concentrations of true 
17-ketosteroids were estimated to be about 0.3 mg. per liter of urine. 
Three 17-ketosteroids were identified with some degree of accuracy: 
dehydroepiandrosterone, etiocholanolone, and 11-ketoetiocholanolone. No 
differences of steroid levels were found between bulls, cows, steers, and 
cows with sexual disturbances . 
Holcombe (54) has reported on an assay of neutral and reducing 
corticosteroids; however no data were given as to the specificity of the 
7 
method he used. The values he obtained suggest that far more cortico-
steroids are excreted than any other steroids in these urines. 
Ungar et al. (130) analyzed calf urine by use of hot acid hydrolysis, 
--
snail juice sulfatase, ~-glucuronidase hydrolysis and column and paper 
chromatography. It was found that the crude ketonic fractions gave an 
average 17-ketosteroid value of 21.5 mg. per 24 hours. Following chromato-
graphy on an adsorbent column, an average value of 13.3 mg. per 24 hours 
was obtained. The average value obtained after eluting zones from paper 
chromatograms was 2.6 mg. per 24 hours. Following the same purification 
procedures as indicated above, the 17-hydroxycorticosteroids decreased 
proportionately to the 17-ketosteroids. The crude extract contained 0.9 
mg. cort i costeroids per 24 hours, 0.3 mg. per 24 hours after column 
chromatography, and 0.11 mg. per 24 hours after paper chromatography. 
From the literat ure cited above, it can be seen that due to the 
presence of ionone derivatives from the diet, any interpretation of uri-
nary steroid excretion using existing methods is particularly hazardous 
( 130). 
General Aspects of Steroid Metabolism in Bulls 
Holcombe (52) reported low urinary levels of corticoids in parturient, 
paretic cows and interpreted the results as being indicative of a low 
adrenal cortica l output of steroids. Holm and Firch (55) found a decreas ed 
ketosteroid excretion following parturition. In other studies, Holcombe 
(53) found an increased excretion of reducing compounds in urine during 
pregnancy. During the last month of pregnancy there was a 2-3 fold 
increase in excretionary rate. After parturition, the excretionary rate 
fell rapidly to the non-pregnant rate within 3-4 days. In cows with 
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retention of the placenta there was little or no fall in the excretionary 
rate. Cows with milk fever showed a much lower excretionary rate than 
healthy cows at the same stage of reproduction. 
Pregnant cows were shown by Putriano (94) to have an increase while 
acetonemic cows showed a decrease of adrenal activity as compared to 
normal, lactating cows. 
Robertson et al. (99) reported that ketotic cows had greater levels 
of plasma 17-hydroxycorticosteroids than did the controls. It was postu-
lated that low urinary levels of corticoids as reported by Putriano (94) 
could result if the liver function of his cattle were impaired. 
Robertson and Mixner (100) reported the plasma levels of 17-hydroxy-
corticosteroids in cattle and found a difference between dry, pregnant 
cows, and milking pregnant cows. The increase in steroid content assoc-
iated with pregnancy was considered to be similar to that reported for 
humans. Bush (7) also has reported an increase in the plasma 17-hydroxy-
corticosteroids during the last month of pregnancy. However, Shaw et al. 
(114), while studying the plasma steroid levels of healthy cattle during 
various physiological states, concluded that, with the exception of 
estrual values, there were no significant differences in plasma 17-hydroxy-
corticosteroid levels. In addition~ Robinson and Macgregor (101) found 
no significant difference in the urinary excretion of steroids in four 
ewes from the time of conception until a few weeks after parturition as 
compared with seasonal fluctuations. This study was complicated further 
by the fact that two of the ewes received from 20-40 IU of ACTH during 
the final three weeks of pregnancy. The steroid levels were high in 
winter and l ow i n surmner with an abrupt fall occurring towards the end of 
pregnancy regardless of treatment. The amount of steroids excreted in 
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urine rew~ined very low inunediately after parturition, rose during lacta-
tion, and dropped again upon artificial termination of lactation. 
Bovine blood and urine are noticeably lower in sex hormones in 
comparison to human or equine urine. According to Meschanks (77), the 
blood of steers and cows contains less than one unit of chick comb growth 
promoting substance per liter in contrast to almost 20 units per liter of 
human blood. A positive comb growth test from bull blood requires from 
300 to 600 ml. of blood per day. 
Fluctuations in total ketosteroid excretion due to season or quality 
of grass were found by Holtz (57). Differences in the metabolism of 
testosterone were found in cattle in contrast to man since the gonadal 
metabolites, androsterone and etiocholanolone, do not occur in cattle 
urine in large quantities as they do in human urine (56). Using paper 
chromatography, spots were found corresponding to the 17-ketosteroids 
dehydroepiandrosterone, etiocholanolone, and 11-ketoetiocholanolone. 
These spots were, however, not considered as conclusive evidence for the 
presence of these compounds. Administration of testosterone or cortico-
t r ophin i ncreased the excretion of these compounds. Every group of animals 
tested contained these three steroids . The possibility of adrenal origin 
for these compounds was suggested by the presence of etiocholanolone, a 
typical testosterone metabolite, in urine from steers. Testosterone, 
when administered in a large dose, was found unaltered in the urine. 
However, unaltered t estos t erone was not found in the urine of aniro~ l s 
receiving l ower doses -of t estosterone. No significant difference in t otal 
ketosteroids could be observed followi ng the injection of ACTH into two 
bulls . Column and paper chromat ograms f r om injected animals did, however, 
dif fer markedly from those of normal animals, especially the peak 
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corresponding to 11-ketoetiocholanolone, dehydroepiandrosterone, etio-
cholandolone, and a fourth 17-ketosteroid though to be androsterone (57). 
For a discussion of testosterone metabolism in man, the reader is 
referred to Fieser and Fieser (32). 
It has also been shown (53) that cortisone administration to adrenal -
ectomized sheep restored the excretory rate of steroids in urine to pre-
operative levels. ACTH and experimentally produced stress resulted in 
increased excretion of reducing corticoids in healthy sheep and cattle. 
Bush (8), likewise, f ound an increase in the 17-hydroxycorticosteroids 
in the blood of ruminants following the injection of 200 IU of ACTH. The 
levels rose from 0-5 to 20-25 ugm. per 100 ml. of blood. From this study 
it was concluded that cortisol is the main Porter-Silber chromogen present 
in the plasma of the cow. However, a 1:1 ratio of cortisol and cortico-
sterone in the blood has been reported (7) from studies using perfused 
bovine adrenals. Although no other corticosteroids have been reported in 
large amounts, Glick (39) has reported on the isolation and identification 
of tetrahydrocortisone and tetrahydrocortisol from cattle bile. These 
steroids were considered to be metabolites of adrenal cortical steroids 
and were obtained from pooled bile after treatment with bacterial 
~-glucuronidase. An increase in the 17-ketosteroid content in the urine 
from diethylstilbesterol -treated lambs was reported by Ruliffson et al. 
( 105). Similarly, Seekles et al. (113) concluded that the 17-ketosteroids 
~ --
of cow and horse urine were predominantly of adrenal origin and that 
gonadal steroids constitute only a small part of this fraction. In addi-
tion, Holm and Firch (55) has shown that surgical stress may increase the 
17-hydroxycorticosteroid a s well as the 17-ketosteroid excretion in 
animals. The urinary concentrat i on of 17-hydroxycorticosteroids was, 
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however, very low. Robertson~ al. (99) also have reported low levels 
of Porter-Silber chromogens in the plasma of cows. 
Miller and Turner (79), using the chick assay procedure, followed 
blood steroid levels after progesterone injections in the ruminant. Sex-
ually mature and pregnant cows were found to excrete appreciable amounts 
of androgen, whereas males and innnature females did not. Injections of 
progesterone into males and immature females increased androgenic activity 
in the feces. 
For a more complete discussion of progesterone metabolism see refer-
ences 56, 73, and 74. 
In man, the 17-ketosteroids arise primarily from two organs with 
approximately one-third coming from the testes and the remaining two-thirds 
coming from the adrenal cortex (1). Thus the 17-ketosteroids are of 
interest clinically since they are derived from the metabolism of both 
the sex and adrenal steroids. 
~ecal Excretion of $,teroid 
·. {~(t/ . ; .. ·,..-,. f , .. ·1.: :;_1) \"." _ l. i_·• .. ) .: (; :-_: ... 
The importance of fecal excretion of steroid metabolites has been 
increasingly recognized in the past few years. The chick assay test has 
been used almost exclusive for fecal steroid assays (13, 29, 41, 97). 
Isotopically labeled steroids have been used during the last few years to 
verify the presence of steroids and steroid metabolites in the feces (142). 
Among the steroids isolated from the bile or feces are metabolites of 
estrogens (29), progesterone (79), adrenal steroids (39, 54, 55, 58, 130), 
and testosterone (57). 
Hyde and William (58) have shown differences in the a.mounts of steroids 
excreted in the urine and feces of the rat which depended upon the route 
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of administration. Hydrocortisone-4-c14 in 50 ugm. doses was given intra-
venously, intramuscularly, sublingually, or intragastrically with a stomach 
tube. More than one-half of the c14 given was found in the feces of normal 
animals; the remainder was found in the urine with no activity being found 
in the expired air. The rate of excretion was greatest after intravenous 
injection and decreased in order with sublingual, intramuscular, and 
intragastric routes of administration. About 91 per cent of the c14 given 
intravenously was excreted in the bile of animals with biliary fistulas, 
whereas only 80 per cent was eliminated via the liver after administration 
by the other routes. 
In the rodent, biliary excretion was predominant while in man only 
a small percentage of administered radioactivity was excreted or detected 
in the feces (39). Biliary excretion in ruminants may be more important 
than the urinary route (53, 55, 79, 100, 130). Based on a nine minute 
half-life of cortisol in the blood (81, 100), adrenal perfusion studies 
(129), and measurements of radioactive steroids in the feces and urine, 
a low urinary excretion of steroids was confirmed in the calf. 
Wright (142) has reviewed the literature concerning the possibility 
of microbial transformations of steroids in the digestive tract of the 
r uminant giving rise to androgens. However, very little work has been 
done to verify this possibility. 
Although an enterohepatic pathway for resorption of some steroids 
may exist, the presence of these steroids in the feces indicates that 
resorption is incomplete (64). Since some steroids appear in the bile 
and not in the urine, the fecal r oute must be important in steroid 
excretion . 
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Diurnal Variations 
Considerable variation in day-to-day excretion of 17-hydroxycortico-
steroids both in single samples and in 24-hour samples is characteristic 
of manmalian organisms (55). A variety of factors influence the excre-
tionary rate, e.g., environment, somatic conditions, variations due to 
differences in activity of endocrine systems, and genetic differences (53). 
The concentration of steroids in the blood of an animal at any one 
time is considered to be the product of the secretory rate, distribution 
into the tissues, and the losses due to metabolism and excretion (62, 90, 
106, 131). 
A urinary diurnal variation was reported by Meschanks (77) for the 
bovine. In this study, a low excretion rate was observed in the morning 
and higher rates in late afternoon and evening. However, Holm and Firch 
(55) encountered a different situation where the greatest concentration of 
steroids occurred in the urine at 8 a.m. rather than at 4 p.m. The latter 
observation corresponds closely to that found in humans where the plasma 
content was higher in the morning than during the day, evening, or night 
(89, 106). The highest content of 17-hydroxycorticosteroids was found 
between 4-9 a.m., usually at 8 a.m., with a rapid decline before 10 a.m. 
The decrease continued slowly until late evening or early night and then 
began to rise again. Although the exact cause of the diurnal rhythm is 
unknown at present, it is believed to be due to fluctuations in the produc-
tion of 17-hydroxycorticosteroids by the adrenal glands. 
That the foodstuff being used for energy could induce changes in 
steroid excretion has been shown by Kurth (66). This does not, however, 
explain the diurnal variations in ionone chromogens in urine (84) or the 
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close correlation of dirunal values in night workers and normal subjects 
as reported by Samuels et al. (106). 
Role of Kidneys on Plasma Steroid Levels 
In humans the "free" steroids in the urine were considered to be 
resorbed up to 80-90 per cent in the kidney tubule under normal conditions 
(110), whereas the glucuronide conjugated corticosteroids were not. These 
results were based on the rates of excretion of these steroid fractions 
before and after a water load. 
In uremia, both free and conjugated steroids accumulated in blood 
concomitant with a decreased urinary excretion. However, the conjugating 
powers for the 17-hydroxycorticosteroids appeared to be normal (62, 106). 
Mode of Steroid Transport in Blood 
It has been shown in man that 96 per cent of the 17-ketosteroids was 
associated with the plasma and no more than four per cent was associated 
with the red cells (136). It was considered highly probable that all of 
the conjugated steroids are in the plasma since this four per cent could 
be due to trapped plasma in the red cell fraction. More recently, the 
in vitro distribution of some 17-hydroxycorticosteroids in blood has been 
studied . Extracts of red cells and plasma showed significant amounts of 
steroids associated with red cells. Of the total steroid content of the 
blood, 25 .1 per cent was reported in the red cell fractions , whereas all 
of the 17-hydroxycorticosteroid glucuronides were found in the plasma . 
It has been shown, however, in human adrenal perfusion studies that 
the blood, after passing through the adrenal gland, contained the same 
amount of conjugated steroids as the arterial blood. The main difference 
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was in the free steroid content which was found to be as high as 280 
;1gm./lOO ml. of plasma. As much as 30 per cent of the total steroids of 
this blood was found in the red cell fraction. In the peripheral circula-
tion where the levels dropped to 2-23,,ugm./100 ml. of plasma, the amount 
of steroids associated with the red cells was similar to occluded blood 
(106). Much lower levels of steroids were found in the body fluids of 
subjects; this difference was attributed to binding of steroids to the 
plasma proteins. 
Protein Binding of Steroids 
Albumin has an extraordinary ability to bind a number of chemical 
substances. Human albumin does bind all the steroid hormones, but the 
strength of binding varies greatly. The binding of estrogenic hormones 
is much greater than the comparatively weak binding of corticosteroids. 
The strengths of the bonds for progesterone and testosterone lie between 
these two extremes. The number of available binding sites on the albumin 
molecule is so great that saturation of the binding sites with steroid 
hormones is never achieved under physiologic conditions. It was found 
that the human albumin molecule appeared to have two primary binding sites 
for corticosterone and testosterone and only one binding site for proge-
sterone and estrone. On this basis albumin would be capable of binding 
in excess of 40 mg. of corticosterone per 100 ml. of human plasma (20). 
It would appear that albumin is the only serum protein that binds 
testosterone (20, 69, 70). Albumin, either bovine or human, has been 
shown to bind the urinary steroid conjugates , especially the conjugates 
of estradiol, estrone, progesterone, and testosterone (117). 
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In human plasma, the 17-ketosteroids have been shown to be associated 
primarily with fTactions IV-1, IV-4, and V; the predominant fraction was 
found to be fraction V (35, 118). 
Little is known concerning the specificity of the binding sites of 
human albumin for individual steroids, but the "saturation" of albumin 
with corticosterone did not alter the binding of estrone, progesterone, 
and testosterone (20). In this respect, an ion-dipole interaction has 
been suggested (70) and the ~-amino group of the bovine serum albumin 
molecule ruled out as the part of the molecule reacting with the steroids. 
Van der Waal's forces have also been implicated in the steroid-protein 
binding (137). Szego (125) has shown that some steroid-protein comp l exes 
are apparently synthesized in the liver by an enzyme-catalyzed reaction 
closely associated with the glucuronosyl transferase system. 
Corticosterone and cortisol, which are loosely bound to albumin, have 
been shown to be tightly bound to the globulin fraction of plasma referred 
to as the corticosteroid-binding glubulin (20) or transcortin ( 107, 118). 
Even though the concentration of transcortin is lower than that of albumin, 
the former binds cortisol approximately 6,000 times stronger than does 
the latter (107). The conjugates of these and other steroids were not 
significantly bound by transcortin. Transcortin has also been demonstrated 
in other animals (rat, guinea pig, rabbit, and alligator) and with competi-
tion studies two types of sites were demonstrated for the binding of 
cortisol and corticosterone. At one s ite, cortisol is definitely bound 
more strongly than corticosterone, while at the second, they are approxi-
mately equal in strength of binding. The binding appears to be quite 
specific for these t wo steroids ( 118). The configuration of the oxygen 
group at carbon-11 is critical in the binding of steroids to transcort i n 
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(20). If the oxygen is present as a ketone group or an 11-alpha hydroxyl 
group in place of the normal 11-beta hydroxyl group, the affinity for 
transcortin is decreased. The introduction of a 9-alpha fluro or aldehyde 
group at carbon-19 (aldosterone) greatly decreased the binding of steroids 
to this protein. 
Distr ibution of Steroids in the Tissues 
Since forces holding the steroids to the plasma proteins are, for 
the most part, comparatively weak (electrostatic and Van der Waal's forces), 
the complex formed would be in equilibrium with the free steroid. As the 
steroid level rises in the blood the proportion taken up by the extra-
vascular tissues increases. However, the difference in distribution of 
the hormone between vascular and extravascular spaces may not be due solely 
to the plasma proteins. The proportion leaving the blood stream would be 
greater with increasing concentration of steroid if absorption occurred 
on extravascular surfaces of if cells such as fibroblasts engulfed diffus-
ible steroid. Thus a very effective system exists where the increase in 
hormone content at the tissue level is greater than the increase in plasma 
concentration providing the extent of protein binding in the blood remains 
unalt ered (106) . 
Factors Affecting Protein Binding of Steroids in the Blood 
Important alterations in corticosteroid metabolism occur during 
pregnancy or during treatment with large doses of estrogens (11, 30 , 51, 
98, 118, 133). These include an increase in plasma cortisol concentration, 
and exaggerated response of plasma levels of cortisol to ACTH, and a 
decrease in removal of cortisol from plasma (20). The administration of 
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estrogens caused greatly increased protein binding of steroids with 
greatly increased levels of the 17-hydroxycorticosteroids. A decreased 
total daily production of hydrocortisone by the adrenal has been reported 
following estrogen administration (11). Protein binding of the steroids 
probably prevents hypercorticism during estrogen therapy by rendering the 
steroids biologically inactive through restricting their distribution, 
thereby rendering them unavailable for metabolism (98, 107). Concomitant 
with this increase of steroids in the blood was a decreased excretion of 
the conjugates in the urine (11, 51, 98, 133). 
Currently there are two main concepts as to the nature of increased 
protein-bound steroids in the plasma. One group (20) believes that there 
are three plasma proteins involved in protein-steroid binding (albumin, 
transcortin, and a corticosteroid-binding globulin similar to trans-
cortin). This third protein cannot be separated using electrophoretic 
techniques, but was differentiated on the basis of physical properties. 
The second group (107, 118) believes that there are only two plasma 
proteins responsible for steroid binding and that the increase in steroid-
protein binding is due primarily to increased levels of transcortin in the 
b lood. The main difference of interpretation between the two groups 
appears to be due to differences in methodology . 
A somewhat similar phenomenon occurs with respect to the thyroxine 
binding protein (30, 42, 95). Pregnancy, as well as estrogen injections, 
increase the amount of circulating thyroxine-binding protein in the blood 
(95). Administration of estrogen increases the thyroxine-binding capacity 
of serum, increases the concentration of PBI, increases pituitary secre-
tion of thyrotropin, and increases thyroid activity (30). 
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Thus it can be seen that the plasma steroid level does not aid in 
elucidating the finer differences in adrenal function since the rate of 
steroid synthesis, degradation, and the distribution volume of the steroid 
are all factors that modify the plasma concentration. However, measure-
ments of turnover rates make it possible to ascertain if abnormally high 
concentrations of plasma steroid are the result of increased rates of 
synthesis or decreased metabolism of circulating steroids (62, 90, 131, 
106). 
Role of the Liver in Steroid Metabolism 
The rate of removal of steroids from the blood is markedly influenced 
by liver function (31, 106, 136). Changes in blood flow through the liver 
alters the rate of removal and conjugation of steroids (106). Shunting 
blood from the portal vein to the vena cava decreased cortisol removal 
while shunting aortal blood into the vena cava increased its removal. 
This increased removal from the blood was attributed to accelerated reduc-
tion and conjugation of the steroids. When liver function was reduced, 
there was a significant change in the slope of the removal curve. Simi-
larly, a slower rise and l onger duration inthe appearance curve was 
observed for the conjugated 17-hydroxycorticosteroids (106). Acute, 
hepatic venous congestion s everely impaired the enzymatic reduction of 
ring A of various steroids in both the male and female (144). Impairment 
of conjugation due to liver damage appears to be due to impaired reduct ion 
of steroids and not to the conjugation system. This is evident by the 
fact that the tetrahydro derivatives of various steroids were conjugated 
strikingly faster than cortiso l when infus ed into the animals (31). A 
close correlation has been noted between the size of the adrenal glands 
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and the capacity of the liver to inactivate adrenal cortical steroid 
hormones by ring A reduction in vitro. Neither ACTH nor adrenal steroids 
increased the capacity of the liver to inactivate corticosteroids. How-
ever, diminution of hepatic capacity for steroid inactivation by surgic-
ally removing two -thirds of the liver resulted in secondary adrenal 
atrophy (131). 
Although the adrenal steroids do not affect ring A reduction in the 
liver, thyroxine and the sex hormones do alter this ability (131, 143, 
145). Female rats have larger adrenals than males and the in vitro ring 
A reduction capacity is also greater in the female. There is, however, 
a reversal of the hepatic-adrenal-sex difference in the hamster with the 
male having larger adrenals and a greater capacity to inactivate steroids 
than does the female. 
Castration increases while testosterone decreases the 64-steroid 
hydrogenase activities in male rats. Neither castration nor estrogen 
administration had any appreciable effect in females. The sex difference 
persists, although diminished, in animals castrated when young and allowed 
to grow to maturity (143). The sex difference in reduction of the 17, 21-
dihydroxy-20-ketone side chain of cortisone has been shown to be greater 
in male rats than in females (127). It was also shown that the male 
hormore promoted the ability of the liver to reduce the sidechain of 
cortisone while the female hormone had the opposite effect. 
Thyroid hormones increase total hepatic activity for in vitro ring A 
reduction of cortisol in both male and female rats. Alterations in 
4 thyroid state affected the total amount of ,6. -steroid hydrogenase, liver 
size, the amount of enzyme per gram of liver, and the availability of 
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TPNH1 (145). In addition, it has been postulated that triiodothyronine 
increases bilirubin excretion by accelerating maturation of the glucuronosyl 
transferase system in the newborn human (138). 
Other tissues in addition to the liver can metabolize steroids. Kidney 
and spleen were found to be active in metabolizing 11-dehydro-17-hydro-
cortisone while blood serum, brain, and muscle were inactive (67). Rat 
brain, diaphragm, heart, gastrointestinal tract, thymus, leg muscle, and 
kidney were assayed for their ability to metabolize cortisol and cortisone. 
Only the kidney was found to be active to any extent (72). However, 
cortisol has been found to be metabolized by loose connective tissue (3). 
In addition, extensive metabolism of intravenously administered proge-
sterone and cortisol has been shown to take place in eviscerated rats 
where the liver, spleen, and gastrointestinal tracts have been removed 
(4, 5). Of the metabolites isolated, neither the water soluble conjugates 
nor the tetrahydro derivatives were found. 
Mechanism of Glucuronide Formation 
One of the pathways for the excretion of hormones and other alcoholic 
or phenolic compounds in the urine or the bile is through conjugation with 
glucuronic acid (84). In this form, they possess little or no physiolog-
ical activity and an enhanced water solubility (59). The physiologically 
1The abbreviations used throughout the text are: TPNH, reduced tri-
phosphopyridine mucleotide; UDPGA, uridine diphosphoglucuronic acid; UTP, 
uridine triphosphate; UMP, uridine monophosphate; UDPglucose, uridine 
diphosphoglucose; ATP, adenosine triphosphate; ADP, adenosine diphosphate; 
iPP, inorganic pyrophosphate; DPN, oxidized diphosphopyridine nucleotide; 
DPNH, reduced diphosphopyridine nucleotide; PAPS, adenosine-3'-phosphate-
5-phosphosulfate; H4E, tetrahydrocortisone; H4F, tetrahydrocortisol; and 
PB!, plasma bound iodine. 
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active hormone may in some instances serve as the substrate for conjuga-
tion; in other cases, metabolism and inactivation take place prior to 
conjugation. The glucuronosyl transferase system resides in the parti-
culate fraction of cells referred to as the microsomes (60). 
The formation of a glucuronide conjugate requires "activated" 
glucuronic acid; the glucuronide containing compound is referred to as 
UDPGA. Glucuronic acid per~ is poorly utilized in conjugation studies 
(59). Glucose, however, is a good precursor of UDPGA (27, 28). The 
sequence of events leading to the formation of this compound is as follows 
(26, 124, 126): 
Glucose+ ATP------------------~> Gl ucose-6-phosphate + ADP 
Glucose-6-phosphate > Glucose-1-phosphate 
Glucose-1-phosphate + UTP ~ UDPGlucose + iPP 
UDPGlucose + DPN ~ UDPGA + DPNH + H+ 
The oxidation step for the removal of hydrogen and the addition of 
oxygen at C-6 of UDPGlucose is a two step system (124). 
The transfer of glucuronic acid from UDPGA requires a transferase 
enzyme. At present it is not known whether there is only one enzyme for 
all substrates or a specific enzyme for each substrate (124). The follow-
ing reaction characterizes the transfer of glucuronic acid from UDPGA to 
its acceptor (26, 59, 123, 124). 
UDPGA + Aglycone -----------------;> Aglycone glucuronide + UDP 
Through this system ether, ester, and normal glucuronides of foreign 
or endogenous compounds can be formed. 
Tissues other than the liver have been implicated in glucuronide con-
j ugation (33). The kidney of man, mouse, and guinea pig (25), the 
duodenal mucosa in rat (43, 45), skin in mouse and guinea pig (122), and 
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the avian aqrenal gland (87) have been reported as being able to conjugate 
various substrates with glucuronic acid. However, !!l vivo studies have 
failed to show significant amounts of the conjugates being formed when the 
liver, kidney, and intestinal tract were removed (4, 5). Studies using 
liver, kidney, and intestine of mice have shown that the kidney and liver 
of this animal conjugate steroids while the intestine does not. It also 
has been shown that the parenchymal cells of the liver are the cells 
responsible for controlli~g the conjugation of steroids, and that 
reticuloendothelial cells have a large capacity to oxidize and reduce the 
substituted groups of the steroid nucleus. The liver, which contains 
approximately one-third reticuloendothelial cells, actively reduces ring 
A to form tetrahydro steroids which are subsequently cojugated by the 
hepatic cells. The kidney, reducing ring A to a much lesser extent than 
4 the liver, does not conjugate t:.. -3-ketosteroids to any appreciable extent. 
It can, however, conjugate the tetrahydro compounds as readily as the 
liver (121). 
A partial listing of the many compounds that are known to be conjug-
ated with glucuronic acid can be found in the article by Sie and Fishman 
(115). 
Mechanism of Sulfate Conjugation of Steroids 
There is now abundant evidence to show that many compounds are 
conjugated with sulfate as well as with glucuronic acid (6, 21, 88, 103, 
104, 108). +I- --In the presence of ATP, Mg , and so4 ions, yeast and 
presumably mammalian cells synthesize PAPS by a two-step reaction as 
follows ( 120): 
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ATP + sol~ + Mg* <-----~Adenosine-5' -phosphosulfate + iPP 
Adenosine-5'-phosphosulfate +ATP------------------~ PAPS+ ADP 
The first step in this sequence is reversible while the second step 
is non-reversible. 
Kidney, spleen, heart, lung, and testes have been shown to produce 
PAPS and transfer the sulfate from this compound to endogenous acceptors 
(120). Evidence also was obtained suggesting that some of the endogenous 
acceptors were phenols and possibly steroids. In addition, evidence has 
been put forth indicating that there are many sulfokinases in mammalian 
liver cells with specific enzymes for specific substrates (88). These 
same workers demonstrated the presence of phenol sulfokinase in kidney 
and intestine, but the steroid sulfokinase was demonstrated only in the 
liver. 
The t .. ransfer of so4 -- from PAPS requires a specific sulfokinase in 
a reaction as follows: 
PAPS + ROH -----------~ ROS03H + ADP 
CHAPTER III 
MATER.IA~ AND METHODS 
PART I: 
The following experimental procedures were designed to determine the 
levels of steroids in the urine, feces, and plasma of bulls before, during, 
and after intramuscular injections of testosterone propionate. 
Experimental Bulls 
Seven, Hereford.range bulls, 21-26 months old at the beginning of the 
experiment, were selected on the basis of physical and genetic uniformity. 
One bull was discarded because of temperament. The experimental animals 
were kept in a one-half-acre exercise lot containing a 16 x 16 ft. shelter 
equipped with an evaporator cooler to give year-round relief from the 
elements. 0 Daytime temperatures in the shed did not exceed 85 F. 
The bulls were fed a ration of prai~i,e hay .an:d ·a protein·-vitamin· 
mineral supplement to permit normal growth. 
Experimental Treatment 
The experiment consisted of a 17-week control period, an 18-week 
injection period, and a 34-week recovery period. The preliminary period 
started January 10, 1958. Collections of blood, urine, and feces were 
taken every other week throughout the course of the experiment which ended 
April 27, 1959. The first 17 days of the control period served to acquaint 
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the bulls with the exercise pens, personnel, stalls, and other equipment 
used in collecting the samples. 
During the injection period, the bulls received individual doses of 
250 mg. of testosterone propionate in cottonseed oil, intramuscularly, 
three times weekly (68). The dosage was calculated, from that used in 
man, with consideration given to weight differences (12, 47, 112). 
The collection of data was carried over through the recovery period 
in order to follow steroid metabolism after injections had ceased. 
Collection of Samples 
Approximately 100 ml. of blood were collected using 100 ml., hepari-
nated centrifuge tubes. The animals then were placed in stalls provided 
with feed and water which were given ad libitum. Two bulls were placed 
in the stalls daily. The animals were assigned to the stalls at random 
but were placed in the stalls the same day of the week in order to keep 
the time interval between samples constant. Twenty-four-hour urine samples 
were collected using rubber urinals suspended under the animal with heavy 
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straps. The urinal was connected to a garden hose which passed through 
a hole in the floor of the stall to a five-gallon galvanized tank placed 
under each stall. Being next to the concrete f loor and insulated by the 
wooden floor of the stall, the urine was kept several degrees below room 
temperature. The urine was measured volumetr ically, subsampled, and 
taken to the central laboratory where the samples were stored in the 
freezer until analyzed. 
Metal trays were placed at the rear of the stalls to collect the 
feces during the 24-hour period. The feces were weighed, mixed thoroughly, 
2navol Veterinary Rubber Products, Providence, Rhode Island. 
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subsampled, and taken to the central laboratory where they were stored in 
the freezer until analyzed. 
Semen samples collected with an artificial vagina, were taken weekly. 
Testicular biopsies were taken May 5, 1958, September 5, 1958, and April 
27, 1959. Periodic measurements of testicular size were reported by 
Meinecke and McDonald (76). 
Blood Analysis 
After centrifuging the blood for 45 min. at 3,000 RPM in an Inter-
national centrifuge, type SB, and plasma was aspirated off and analyzed 
for steroid content as described below. Ten ml. of plasma were extracted 
with 10 ml. followed by two five ml. aliquots of chloroform. The chloro-
form layers were pooled and washed with five ml. aliquots of 0.1 N NaOH 
and 0.1 N HCl according to the method of Nelson and Samuels (86). This 
fraction was designated as the "free steroids". 
The "glucuronide-bound" steroids were liberated by adjusting the 
samples to pH 5.0 with acetate buffer, adding several drops of chloro-
form, and incubating the mixture with 0.5 ml. Ketodase (2,500 units beef 
0 liver ~-glucuronidase - Warner Chilcott) at 45 C for 15 hours (38). 
Chloroform was added to the mixture since it has been shown that greater 
yields of glucuronide-bound materials are obtained when incubated in the 
presence of small amounts of chloroform (116). The steroids were extracted 
and purified as described above. 
The "sulfate-bound" steroids were liberated by adding four ml. of 
concentrated HCl and the mixture incubated at 80° C for 20 min. The 
steroids were extracted and purified as indicated above. 
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The three steroid fractions were blown to dryness and analyzed using 
the lsonicotinic Acid Hydrazide (INH) reaction of Weichselbaum and 
Margraf (134) using a battery operated Spectronic 11 20 11 photometer and 
one-ml. microcuvettes (Pyrocell). 
The "total" steroid fraction was obtained by summation of the 11 free", 
''glucuronide", and "sulfate-bound" fractions. 
An additional 40 ml. aliquot of plasma was adjusted to pH 5.0 using 
acetate buffer. Several drops of chloroform were added and the mixture 
0 incubated with two ml. of Ketodase (10,(Xl) units) for 15 hours at 47 C. 
After being extracted three times with 15 ml. chloroform per extraction. 
the extracts were pooled and washed with acid and base as indicated earlier. 
The 17-ketosteroids were separated from the 17-hydroxycorticosteroids using 
column chromatography (86), 
The 17-ketosteroids were analyzed with the Zimmerman reaction. The 
method of Callow~ al. (9) was modified by using methanol instead of 
ethanol as the solvent in preparing the 2.5 N KOH (63) and the mixture 
stabilized with ascorbic acid (44). The two per cent m-dinitrobenzene 
was made up in methyl cellosolve to increase the stability of the color 
(140). After stoppering the tubes, the mixture was incubated for three 
hours in an ice bath at o° C. The ice bath containing the samples was 
placed in the refrigerator to avoid light during the incubation period. 
Following incubation, one ml. of 80 per cent ethanol was added to each 
tube and the samples read in the Spectronic 11 20" photometer using micro-
cuvettes as indicated earlier. 
29 
Fecal Analysis 
Approximately five grams of feces were weighed out from each sample, 
ten ml. of water were added, and the samples adjusted to pH 5.0 using 
acetate buffer. After incubating with one ml. of Ketodase (5,000 units) 
for 15 hours, the mixture was extracted, washed with acid and base, and 
the chloroform extract run through a Florisil column of which contained 
two cm. of activated Norit (charcoal) on top of seven cm. of adsorbent to 
remove interferring pigments. Us i ng this procedure, the neutral steroids 
were separated into 17-ketosteroids and 17-hydroxycorticosteroids contain-
ing both the free and glucuronide-bound steroids. The steroids were 
eluted from the co l umn using positive pressure. Norit was activated 
according to the method of Roe and Kuether ( 102); the Florisil was acti-
0 
vated by heating overnight at 375 C and washing with chloroform before 
using (34). After separation, the 17-ketosteroid samples were split and 
analyzed using both the INH reaction and the modified Ziil'ailerman reaction 
for comparative purposes. The 17-hydroxycorticosteroids were analyzed 
with the INH reaction. All samples were read in the Spectronic "20". 
An additional five-gram aliquot of feces was analyzed according to 
the procedure for plasw~ free, glucuronide, and sulfate-bound steroid 
fractions. The pooled extracts for each fraction were filtered through 
two cm. of activated Norit in chromatographic columns to remove interfer -
ing pigments before assaying for steroid content. 
Urine Analysis 
A five ml. sample of urine was adjusted to pH 5 .0 with acetate buffer 
and incubated with one ml. of Ketodase ( 5,000 units). Following i ncubation, 
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the urine samples were extracted and run through Florisil columns in a 
manner similar to that described above. The column consisted of five cm. 
of adsorbent and two cm. of 1.6:10 (W/W) ratio of Norit:Florisil. Both 
compounds were activated before use as described earlier. Positive 
pressure was applied to elute the steroids. 
The 17-ketosteroid samples were split and assayed by both the modified 
Zirranerman reaction and the INH reaction as previously described. The 17-
hydroxycorticoids were assayed using the INH reaction. 
Additional five ml. samples of urine were assayed for free, glucuro-
nide-, and sulfate-bound steroids using the same procedure as described 
for the plasma samples. One ml. of Ketodase (5,000 units) was used for 
the glucuronide hydrolysis while four ml. of concentrated HCl were used 
for the sulfate hydrolysis. 
PART II: 
The following procedures were followed in order to evaluate the 
glucuronic acid transferase mechanism in liver and adrenal tissues from 
rats, dogs, and sheep. Female experimental animals were used in this part 
of the experiment since it has been shown (145) that female rats have 
more active enzyme systems in respect to steroid inactivation and metab-
olism. Cattle were replaced by sheep for economic reasons while rats and 
dogs were used for comparative purposes. 
Experimental Rats 
Mature, non-pregnant, female rats (Holtzman strain) were caged in 
groups and fed Laboratory Chow ad libitum. The rats were sacrificed by 
decapitation, the chest massaged to facilitate the removal of blood f rom 
the body, and the body cavity opened by making a "V" shaped incision 
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extending from the pelvic region to the ribs. The liver or adrenals were 
quickly removed, chilled, weighed, minced, and homogenized. 
Experimental Dogs 
Mature, non-pregnant, female, mongrel dogs were purchased locally and 
held in kennels until sacrificed. The animals were fed Purina Dog Chow. 
The dogs were killed by electrocution, the body cavity quickly opened, and 
the adrenals or liver quickly removed, chilled, minced, weighed, and 
homogenized. In order to get enough tissue for conjugation studies, the 
adrenals from two animals were pooled for each assay. 
Experimental Sheep 
Six, mature, western type, non-pregnant, female sheep were obtained 
locally and fed a ration of prairie hay and a vitamin-mineral-protein 
supplement to permit normal growth. The sheep were killed by electrocu-
tion, the body cavity opened, and the adrenals or liver removed, chilled, 
minced, weighed, and homogenized. 
Tissue Preparation 
Tissues were homogenized in ice cold KC1 solutions in a Pott.er-
Elvejhem homogenizer. A 0.1 M KCl solution was used for microsomal 
preparations (61) while isotonic KCl (1.12 per cent) was used for homo-
genate preparations (93). A 30 per cent homogenate was prepared for all 
tissues except the rat adrenals. Microsomes were prepared by centrifug-
ing the homogenate in a Servall centrifuge at 10,800 x g for 10 min. in 
a cold room (1-2° C) to remove nuclei, mitochondria, and cell debris. 
The supernatant was centrifuged for one hour in a Spinco Model L 
ultracentrifuge at 105,000 x g. The supernatant was discarded and the 
microsomes resuspended in 0.1 M KCl using a Potter-Elvejhem homogenizer. 
Each ml. of resuspended microsomes represented two and one-half grams of 
original tissue. Due to the low yield of microsomes from rat adrenal 
tissue, conjugation studies using microsomes from this tissue were omitted. 
Incubation of Homogenates 
One ml. of homogenate was added to a Warburg flask containing 25 mg. 
glucose, 0.5 ml. buffer, 0.5 ml. UDPGA (0.086.,,uMoles - Sigma), and 0.5 ml. 
aqueous solution containing 0.140 }!Moles of steroid. In a like manner, 
one ml. of homogenate was added to a 30 ml. test tube containing 0.5 ml. 
buffer, 0.5 ml. distilled water in place of the UDPGA, and 0.5 ml. steroid 
solution (0.140.,.uMoles). This tube, containing no UDPGA, served as a 
control to ascertain the amount of steroid that disappeared during incuba-
tion. The buffer of Potter~ al. (93) was used in preference to Krebs-
Ringer-Phosphate buffer (128) because the Potter buffer has a higher 
concentration of potassium ions and lower sodium content. This buffer 
was used since it has been shown that larger Q02 resulted using this 
buffer with bovine liver homogenates (109). Greater transferase activity 
was also achieved with the isotonic KCl instead of 0.25 M sucrose as the 
homogenizing medium. 
Incubation of Microsomes 
Incubations were carried out in 15 x 125 nun. pyrex test tubes under 
constant shaking at 37° C for one hour. The substrates , dissolved in 
methanol, were added to the tubes and blown to dryness before adding the 
other ingredients. Two tubes were used for each sample . One tube 
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containing 0.1 ml. UDPGA (0.4},lMoles), 0.55 ml. Tris buffer (61), and 0.1 
ml. microsomes was incubated to measure transferase activity. Similarly, 
a second tube containing 0.1 ml. distilled water, 0.55 ml. Tris buffer, 
and 0.1 ml. microsomes was not incubated but served as a control in order 
to calculate the disappearance of the substrate. 
Inhibition Studies 
Sheep liver mic~osomes were prepared as described above. The incuba-
tion mixture and procedure were the same as indicated above except for the 
addition of 0.4}1Moles of competitive substrate (H4E) and the addition of 
the substrates in 0.0, 0.1, 0.2, 0.3, and 0.4,,uMole increments. The 
substrates were phenolphthalein and p-nitrophenol. Competitive conjuga-
tion incubations were carried out in duplicate. Separate assays using the 
same enzyme preparation were used to establish normal rates for the enzyme 
preparation for comparative purposes. 
Substrate Determinations 
Steroid determinations for both the homogenate and microsomal studies 
were analyzed by boiling the test tubes containing the incubation mixture 
minus the UDPGA in boiling water for two min. to inactivate the enzymes 
and precipitate the proteins. The contents of the Warberg vessels after 
incubation were transferred to test tubes and boiled as indicated above . 
Both series of tubes were extracted three times with two and one-half 
volumes of chloroform and the extracts pooled, washed with acid and base, 
evaporated to dryness, and the steroids separated from interfering 
materials using column chromatography. The columns were prepared accord-
ing to the method of Nelson and Samuels (86). The columns were washed 
34 
with chloroform (34), the sample in five ml. of chloroform was added to 
the column, and the column developed using 25 ml. of chloroform followed 
by 10 ml. of three per cent (v/v) methanol in chloroform. This was 
followed by 60 ml. of three per cent (v/v) methanol in chloroform and 
finally by 20 ml. of 40 per cent (v/v) methanol in chloroform. .Only the 
last two fractions contained the steroids. These two fractions were 
combined, blown to dryness, split, and analyzed for steroid content 
using the Robertson-Mixner modification of the Porter-Silber method (100). 
The samples were read in a Beckman model DU spectrophotometer using micro 
cells (Pyrocell). 
Phenolphthalein and p-nitrophenol determinations were accomplished 
after precipitation of the protein with three ml. of 95 per cent ethanol. 
The samples were centrifuged to remove the precipitate and one ml. aliquots 
were taken from each tube for substrate assays. Phenolphthalein samples 
were assayed in duplicate according to the method for ~-glucuronidase 
assay (116). p-Nitropnenol was assayed in duplicate using the method out-
lined by Isselbacher and McCarthy (61). The samples were read in a Coleman 
Jr. spectrophotometer. 
Microsomal protein determinations were accomplished using the Biuret 
test as outlined by Gornal et al. (40). 
--
CHAPTER IV 
RESULTS AND DISCUSSION 
PART I : 
Data were co l lected from siXt Hereford bulls over a period of 64 
weeks; samples of blood, feces, and urine were collected once every two 
weeks during the course of the experiment except for the last two months 
when they were collected once every four weeks. A 12-week control period 
was followed successively by an 18-week injection period and a 34-week 
recovery period. The samples collected during these three periods were 
analyzed according to the procedure outlined in Table I; the results are 
sunnnarized in Table II. Since very little is known concerning the metab-
olism of testosterone in the male ruminant, steroid levels were followed 
in the plasma, urine, and feces. In addition, many of the conventional 
tests used to fol l ow steroid metabolism in humans are of little value in 
ruminants; therefore, various fractionation procedures as well as colori-
metric tests were used to follow variations in the steroid fractions of 
the plasma, urine, and feces. In this connection, a search of the litera-
ture has failed to show any attempt to correlate blood, urine, and fecal 
levels of any steroid fraction in the bull over a prolonged period of time. 
Steroid levels, determi ned by the !NH method, for plasma, urine, and 
feces are plotted in Figures 1, 2, and 3, respectively. Inspection of 
these figures shows l arge variations in all fractions, but especially in 
the conjuga ted and total fractions. Since it has been shown previous l y 
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Samp_les 
Plasma 
Feces 
Urine 
TABLE I. ANALYTICAL PROCEDURES FOR ISOLATION AND ASSAY OF STEROm FRACTIONS 
Procedure for 
Isolation of Steroids 
(10 ml.) 
1. Extracted with CHCl3 
2. Incubated with ~-glucuronidase 
& re-extracted with chloroform 
3. Boiled in acid & re-extracted 
4. Summation of the above 
(40 ml.) 
1. Incubated with ~-glucuronidase, 
extracted with CHC13, & separa-
tion using column chromatography. 
{Florisil) 
(5 gm.) 
_ 1. Extracted with CHC13 
2. Incubated with ~-glucuronidase 
& re-extracted with CHCl3 
3. Boiled in acid & re-extracted 
4·.,- Summation of the above 
(5 gm.) 
5. Incubated with ~-glucuronidase, 
extracted with CHCl31 & separa-
tion using column chromatography 
{charcoal and Florisil). 
1. 
2. 
3. 
4. 
(5 ml.) 
Extracted with CHC13 
Incubated with ~-glucuronidase 
& re-extracted with CHCl3 
Boiled in acid & re-extracted 
Summation of the above 
(5 ml.) 
5. Incubated with ~-glucuronidase, 
extracted with CHCl3 1 & separa-
tion using column chromatography 
(charcoal and Florisil). 
{Neutral) 
Steroid Fractions Obtained 
Free 
Glucuronide 
Sulfate 
Total 
17-Ketosteroids 
(Free and_glucuronide) 
Fre_e 
Glucuronide 
Sulfate 
Total 
17-Ketosteroids 
(Free and glucuronide) 
17-0H Corticosteroids 
(Free and -glucuronide) 
Free 
Glucuronide · 
Sulfate 
Total 
17-Ketosteroids 
(Free and glucuronide) 
17-0H-Corticosteroids 
(Free and glucuronide) 
Testsutilized 
INH 
INH 
INH 
INH 
Zimmerman 
INH 
INH 
INH 
INH 
INH & Zimmerman 
INH 
INH 
INH 
INH 
INH 
INH & Zimmerman 
INH & Zimmerman 
\,J 
O' 
TABLE II. AVERAGE STER.Om CONTENT OF PLASMA, URINE, AllD FECES OF VARIOUS STER.om 
FllAC'tIONS DURING TllllEE EXPERIMENTAL PERIODS 
Control Period Infection Period 
1958 
1-27 2-10 2-24 3-17 3-31 4-14 4-28 5-12 5-26 6-9 6-23 7-7 7-21 8-4 8-18 9-1 · 
Plasma (INH) Free (ugm./ml.) ·0.13 o.oo 0.11 0.67 0.90 3.98 6.29 2. 79 4.34 2.00 
Gluc (ugm; /ml.) 18.71 17 .60 29.34 5.26 11.51 24.82 26.39 27.07 36.97 38.06 
so4 (ugm./ml.) 19.39 33.01 41.93 14.61 .32.08 12.29 11.36 3.16 11.38 3.31 
Tota 1 ( ugm. /ml • ) 38,23 50.61 71.38 20.54 44.49 41.09 44.04 33.02 52.69 43.37 
Urine (INH) Free (ugm. /ml.) 2.48 2.51 . 2.68 3.40 6.20 8.09 
Gluc (ugm. /ml.) 8.97 7.85 9.77 8.11 11.68 5.64 
so4 (ugm./ml.) 14.-09 15.49 11.83 12.11 15.29 16.70 
Total (ugm./mL) 25.S4 25.85 24.28 23.62 33.17 30.43 
Feces (INH) Free (ugm./gm.) 116.10 96.99 89.29 80.67 * 79.13 66.01 
Gluc (ugm./gm.) 103.21 63.95 77.15 63.87 * 47.30 28.43 
S04 (ugm./gm.) 71.99 71.23 52.16 41.96 * 33.80 37 .52. 
Total (ugm./gm.) 291.31 232.17 218.59 186.50 160~23 131.96 
Plasma (Zimmerman) 17-Ketosteroids (ugm./1111.) 0.26 0.34 0.18 0.44 1.30 0.99 1.64 1.12: 3.79 1.30 · 1.37 0.56 0.48 0.71 
. Urine (Zimmerman) 17-Ketosteroids (ugm./ml.) 25.61 23.68 25.80 31.92 23.66 21~37 19.34 21~03 ~2.09 22.68 29.38 39.56 20.37 38.70 52.00 48.37 
Urine (INH) 17-Ketosteroida (ugm, /ml.) 8.72 7.08 8.43 5.5.9 10~57 8.09 10~73 5.39 7.78 9.45 13.84 
) 
6.32 7.18 13.07 il.83 
Urine (INH) 17-0HCS (ugm./mi.) 0.88 0,20 2.00 0.48 0.66 0~70 0.65 * 1.01 0.24 0.62 0.78 0.93 0.38 0.34 0.58 0.72 
Feces (Zimmerman) 17-ketosteroids (ugm./gm,) 102.21 40.26 40.92 159.71 209.27 156.38 128.40 ·81.84 116.35 22.20 192.72 140.83 80.09 224.60 
Feces .(INH) 17-Ketosteroids (ugm./gm.) 39.59 37.86 139.43 177.04 116.67 104.09 55.60 69.83 116.23 128.26 72.73 76.44 98.18 
Feces (IRR) 17-0H (ugm./gm.) 7.17 10.07 16.51 31.95 38.56 21.65 23.89 25.99 30.04 19.02 24.92 8.69 10.08 14.24 
·. 
*indicates average·on five instead of six animals. 
'w 
--.J 
TABLE II. (Continued) 
Recove!Z Period 
1958 1959 
9-15 9-29 10-13 19-27 11-10 11-24 12-8 12-22 1-5 1-19 2-2 2-16 3-2 J-20 ~4-27 
Plasma (INH) Free (ugm. /ml.) 2.97 1.18 3.31 0.33 0.63 1.69 2.30 o.oo 0.41 o.oo o.oo 1.12 1.36 4.37 3.66 
Gluc (ugm. /ml.) 38.39 47.42 56.82 46.51 57.03 39.95 19.02 118.40 147.02 63.09 91.88 102.91 74.51 43.87 38.37 
S04 (ugm. /ml.) 17.90 12.42 16.89 17.01 19~36 17.76 23.06 39.79 97.09 45.59 82.74 24.95 40.58 3.38 i2.36 
Total (ugm./ml.) 59.26 61.02 77.02 63.85 70~62 59.40 44.38 158.19 244.52 108.68 174.98 .128.98 116.45 51.62 54.39 
Urine (INH) Free (ugm./ml.) 4.40 3.44 3.92 4.41 8~14 
Gluc (ugm. /ml.) 10.20 8.14 7.68 8.47 * 6.33 
so4 (ugm./ml.) 15.10 14.82 18.67 15.72 17~28 
Total (ugm./ml.) 29.70 26.40 30.27 28.60 31~75 
Feces (INH) Free (ugm./gm.) 51.45 67.93 52.73 62.72 25.17 
·Gluc (ugm./gm.) 30.16 63.10 32.76 45.39 31. 78 
so4 (ugm./gm.) 40.12 53.()2 29.81 46.73 45.21 
Total ·(ugm./gm.) 121.73 184.05 115.30 -1.54.84 102.16 
Plasma (Zimmerman) 17-Ketosteroids (ugm./ml.) 0.31 0.44 0.40 0.49 0.33 0.72 0.16 0.66 1.27 0.24 0.20 1.68 0.67· 2.21 2.52 
Urine (Zimmerman) 17-Ketosteroids (ugm,/ml;) 37.07 42.96 41.18 32."91 40.88 38.32 '-37 .08 22.51 34.97 26.66 36.48_ 36.69 50.76 41.28 48~72 
Urine (INR) 17-Ketosteroids (up. /ml.) 9.16 15.87 9.25 10.83 8.07 9.59 12.29 5.92 10.62 6.21 12.43 8.30 10.32 "10.31 12~29 
Urine (INH) 17-0HCS (ugm./ml.)_ 0.76 1.28 0.65 0.72 1.45 1.01 1.20 ·0.13 0.83 1.11 0.74 0.80 * 1.05 
Feces (Zimmerman) 17-Ketosteroids (ugm./gm.) 227.02 228.97 217.53 164.02 174.46 49.71 42.90 .236.76 202.05 311.79 103.83 158.54 143.95 183.31 145.28 
Feces (INR) 17-Ketosteroids_ (ugm. /gm.) 97.08 95.62 109.76 106.66 131.97 75.24 65.01 96.09 - 98.·18 93.80 104.66 75.08 · 76.75 61.26 68.83 
Feces (INH) 17-0H (ugm. /gm.) 23.89 17.70 19.64 14.24 24.31 9.31 10.49 13.30 ·15.84 10.55 12.11· 7.02 7.84 7.98 · 9.37 
-
* Indicates average on five instead of six animals. 
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Figure 3. Free, Glucuronide, Sulfate, and Total (INH) Steroid Content of Feces 
During Three Experimental.Pe~iods 
~ ,,_. 
42 
that all fractions are comprised mainly of ionone derivatives and metabo-
lically inactive steroids (56, 57, 13), the free steroids were reported 
in Figure 4 using an expanded scale to give more detail as to the nature 
of the fluctuations in this more active fraction. Many factors affect 
the levels of steroids in the blood (62, 90, 106, 131) tending to give 
erroneous impressions as to their physiological significance; therefore, 
it also was deemed necessary to plot the glucuronide, sulfate, and total 
(INH) steroid content of the plasma, urine, and feces in separate graphs 
(Figures 5, 6, and 7, respectively). This was done since steroids can 
build up in the plasma due to protein binding and still not be metabo-
lically active ( 106). In addition, this method of plotting the data also 
helps in visualizing which route of excretion predominated for each 
steroid fraction. 
The data from the plasma (Zimmerman) and urine (INH and Zimmerman) 
were plotted in Figure 8 for comparative purposes. The data for the 
fecal 17-ketosteroid (Zimmerman) and 17-ketosteroid (INH) were plotted 
in Figure 9. Likewise, the urinary 17-hydroxycorticosteroids (INH and 
Zimmerman) were plotted in Figure 10. The ~eproductive data obtained from 
the same animals used in this experiment are summarized in Figure 11 for 
the semen values and Figure 12 for testicular volume. Similarly, the 
fecal dry-matter excreted and the volume of urine voided were plotted in 
Figure 13. 
The values obtained from the plasma, urine, and feces have been 
expressed in terms of,.ugm. per ml. for plasma and urine while values for 
the feces were expressed as ,ugm. per gm. of feces on a dry-matter basis. 
This method was used since there was considerable variation in daily 
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Figure 8. Plasma and Urinary 17-Ketosteroid (Zimmerman and Urinary 17-Ketosteroid (INH) .p. 
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excretion of both urine and feces (Figure 13). It was felt that the 
content of steroids per ml. or gm. of material would contain less varia-
tion and be better for comparative purposes than total steroids excreted 
per day since the amount of steroid e,wreted per day increased, irrespec-
tive of treatment, as the experiment progressed. There was also an 
increase in total chromogens excreted per day due to an increased feed 
intake associated with an increased maintenance requirement of these 
animals.· 
Correlation of Reproduction with Steroid Metabolism 
Since the reproductive data gathered by Meinecke and McDonald (76) 
are to be compared with the data on steroid metabolism reported in this 
study, the results of the previous study are summarized below. Semen 
samples were collected and analyzed for volume, spermotozoa per ml., 
total spermatozoa per ejaculate, motility, and per cent abnormal forms. 
Testicular size was measured periodically throughout the course of the 
experiment. Testicular biopsies were taken prior to testosterone injec-
tions, following injections and at the termination of the experiment. No 
great change in average semen volume was observed during the experiment. 
A depression in spermatozoa per ml. during the preliminary period was 
observed which continued through approximately 10 weeks of the recovery 
period which in turn was followed by an increase to slightly above pre-
injection levels at the end of the experiment. An increase in testicular 
size up to the time of testosterone injection was observed; this increase 
was followed successively by a decrease in size until the end of the injec-
tion period and an increase in size up to the time the experiment was 
terminated. Other histological changes such as an increase in connective 
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tissue content, an increase in number and size of Sertoli cells, and loss 
of germinal epithelial cells of the seminiferous tubules innnediately 
following the injection period were reported. Permanent damage to the 
testes did not result from this treatment as indicated by histological 
sections taken at the end of the experiment. 
It has been previously shown by Holtz (57) that the urinary content 
of total ketosteroids increased only slightly after a large (1 gram) injec-
tion of testosterone propionate. He also postulated that 90 per cent of 
the total ketosteroid values obtained from urine was due to non-steroidal 
substances. Calculations from the data reported by Ungar~ al. (130) 
show that only about 12 per cent of both the 17-ketosteroid fraction and 
17-hydroxycorticosteroid fraction remained after column and paper chromato-
graphy. 
Since it also has been shown that many factors such as protein bind-
ing, liver function, kidney function, distribtuion into the tissues, and 
dietary components affect the level of steroids in the blood and urine 
(20, 53, 57, 84), it was deemed necessary to use a more specific assay 
than the Zinnnerman or Porter-Silber assay to follow metabolism of 
testosterone. 
Shortly before this experiment was started, Weichselbaum and Margraf 
(134) published a report on the method of determination of .ci.4-3-ketosteroids 
using the INH reaction. This method was reported by the authors to be 
l~ quite specific for 6 -3-ketosteroids (135). Since the tetrahydro deriva-
I 
I 
tives, as well as the 17-ketosteroids, are generally consi4ered to be 
inactive and do not contain the i-3-keto group, this test, when applied 
to appropriately prepared samples, should give a measure of biologically 
active steroids. However, the possibility of ionone derivatives reactin.g 
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with the INH reagent has not been ruled out. Since a double bond conjug-
ated with a ketone group has been postulated as being required for a 
positive test with this reagent (134), there are probably only two of the 
ionone derivatives (ketone Kand ketone J) listed by Holtz (57) that 
would give a positive test with this assay. It is highly probable that 
other compounds such as progesterone and adrenal steroids might react 
with this reagent. It was assumed in this experiment, however, that during 
the injection period testosterone would be the principle steroid being 
metabolized since it has been shown that the 17-hydroxycorticosteroid 
content of plasma is very low (81, 99). In addition, very little proges-
terone should be present in the male. Any estrogens, if present, would 
have been removed when the chloroform extracts were washed with acid and 
base. Even if the estrogens were present, they should not give a posi-
tive test since they do not contain the .ci.4-3-keto group. 
The 17-hydro}cycorticosteroids were followed in plasma, urine, and 
feces to see if they contributed to the free, glucuronide, sulfate, and 
total INH steroid factions during the course of the experiment. The 17-
hydroxycorticosteroid content of the plasma was determined using the 
Robertson-Mixner procedure. The values which were obtained were so low 
that they are not reported. However, at no time during the experiment 
did the 17-hydroxycorticosteroid content of the plasma show any appreci-
able change in content. Essentially the same low results were found with 
the urine (Figure 10). The urinary level of 17-hydroxycorticosteroids 
was very low and never showed any appreciable change during the course of 
the experiment. The fecal content of 17-hydroxycorticosteroids, however, 
was somewhat higher and showed much greater fluctuations. The signifi-
cance of the fecal 17-hydroxycorticosteroids is not know at present 
56 
since very little is known concerning fec~l excretion of steroids in the 
ruminant. However, the ionone derivatives and other materials in the 
feces could have contributed significantly to the amount of material 
present in the fecal extracts. That materials other than steroids are 
found in the 17-hydroxycorticosteroid fraction after column chromatography 
and do give a positive test with the Porter-Silber reaction was shown by 
Ungar and Dorfman (132). Approximately 12 per cent of the Porter-Silber 
positive material was present after the original crude extract of calf 
urine was purified using column and paper chromatography. 
Holtz (57) has shown that free testosterone appeared in the urine 
of cattle after large doses of this compound. It has also been shown 
that testosterone can be conjugated per.!! without previously being metab-
olized. In this respect, Wotiz et al. (141) have presented evidence for 
the conjugation of testosterone at the carbon-17 position. If testosterone 
is conjugated in the 17 position without the 3-keto group being reduced, 
the compound after hydrolysis would be free to react with the INH reagent. 
Therefore, the INH test could be useful in following testosterone as 
such in the blood, urine, and feces. 
From the data in Figures 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10, it can 
be seen that the only values that correlate in any way with the data 
recorded by Meinecke and McDonald (76) are the urinary and plasma levels 
of free steroids measured by the INH method of Weichselbaum and Margraf 
(134). This, undoubtedly, is due to the fact that ionone derivatives in 
the other steroid fractions overshaddow any change affected by the 
injected steroid. When comparing the data in Figure 4 with the reproduc-
tive data (Figures 11 and 12), the fluctuations of the free !NH steroids 
of the plasma and urine correspond more closely to the spermatozoa per 
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ejaculate than do the other steroid fractions. The urinary free steroids 
rose shortly after testosterone injections were initiated while the plasma 
free steroids failed to rise until after about four weeks. The plasma 
steroid level rose moderately at first then rose very abruptly after 
June 23 and reached a maximum on July 21. The urinary steroids, however, 
f ailed to peak until August 1, some six weeks later. The fact that the 
urinary steroid content reached a peak some six weeks after that of the 
plasma would tend to indicate that the amount of hormone being absorbed 
into the blood increased throughout the injection period while the ability 
of the kidney to excrete this compound in the free state was enhanced . 
Actually, the free steroids in the urine are thought to be resorbed up to 
90 per cent under normal conditions (110). Therefore, a possible explana-
tion for this lag would be due to a steroid pump mechanism for reabsorp-
tion of testosterone from the kidney tubule, which was depressed during 
the prolonged exposure to excessive amounts of this compound. This would 
account for the increase in free steroid content in the urine during the 
time when the content in the blood was decreasing. This decrease in free 
steroid content i n the plasma took place in spite of the fact that t he 
amount of steroid in the tissue was building up due to repeated injections 
of testosterone. Unless there was a local reaction at the sites of 
injection preventing t he absorp tion of the hormone, there should have 
been an increased absorption of the steroid during this period of tiae. 
In this respect, Holtz (57) has found no free testosterone in the urine 
after a small dose, however, significant amounts were present in the urine 
after a large dose of testosterone . 
As will be shown later, the !NH-pos itive, conjugated fractions are 
thought to contain ionone derivatives as well as steroids. Whether the 
presence of ionone derivatives extends to the free INH levels of the 
plasma and urine is not known. However, since the urinary, free (INH) 
levels were so high during the preliminary period, ionone derivatives 
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must have been present in these two fractions. The plasma, free (INH) 
fraction was very low at the start of the injection period. Therefore, 
the question arises as to whether the large increase in free, !NH-positive 
materials in this tissue was due to testosterone or the ionone deriva-
tives. Since the urine and feces did not show ~~rked depressions in the 
various fractions during this period of time, it is unlikely that all of 
material present in the plasma was due to ionone derivatives •. It is highly 
probable that a good portion of the free (INH) fraction in the urine after 
injections of testosterone were started was testosterone. If, however, 
the free (!NH) fractions in the plasma and urine are not comprised pri-
marily of testosterone, then one would suspect that the ionone deriva-
tives and the steroids would behave similarly in the way they were excreted 
and reabsorbed from the tubules. The results of this experiment are 
interpreted on the premise that the rise in free (INH) materials of the 
plasma and urine were due primarily to testosterone. Thus, a homeostatic 
mechanism would appear to be present in the kidney to decrease the rate 
of absorption of steroids from the tubules during chronic exposure to free 
steroids. This would affect an increased excretionary rate of the un-
altered steroid to lower the level of circulating hormone in the blood. 
It is of interest to note the same observation during the period from 
March 30, 1959 to April 27, 1959. The plasma (INH) content rose to a peak 
and dropped off while the urinary content of !NH-positive materials 
continued to rise. Unfortunately, samples were not collected after this 
date to see if the urinary level would decrease at it had done previously. 
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If the free (INH) content of the plasma after February 2, 1959 were due 
to exogenous testosterone, this would tend to indicate that the recovery 
from the injected testosterone was just reaching a peak at the time the 
experiment was terminated. Inspection of the reproductive data (Figures 
11 and 12) shows that testicular volume continued to increase after 
testosterone injections, up to the time the experiment was terminated. 
The semen picture looked somewhat different. The peak in the spermatozoa 
per ejaculate was reached about February 13, 1959. This corresponds with· 
the time when the free (INH) values had started to rise again. The period 
of highest spermatozoa numbers per ejaculate lags by about 48 days, the 
period of cold weather where thyroxine secretion would have been greatest. 
In this respect, it requires at least 48 days for a germinal cell to form 
a spermatozoa (76). Thus thyroxine could have had a potentiating action 
on the action of FSH from the pituitary. Thyroxine is known to have a 
pronounced action on reproduction in the male (85). 
The reason for the fact that the steroid levels in the plasma failed 
to remain at a high level during the entire injection period and shortly 
after, bas been attributed to the ability of the animal to metabolize and 
rapidly excrete the hormone. This failure to maintain high levels of 
steroid in the blood would also tend to indicate that after a certain level 
of steroid is reached in the tissue, a maximum level will result in the blood. 
Injecting testosterone beyond this point would result in decreased levels 
of steroid in the blood through an increased rate of excretion of the free 
steroid and possibly other routes of metabolism and excretion. Although 
it has been shown in man that pretreatment with testosterone before 
surgery failed to demonstrate alterations in plasma, free or conjugated 
corticosteroids (119), prolonged administration could have a demonstrat-
able affect as far as testosterone metabolism and excretion are concerned. 
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The data from this e:xperiment would tend to substantiate the claims that 
small doses of testosterone are more effective in producing the rebound 
phenomenon than larger doses (49, 71, 146) by altering the rate of elimina-
tion of this hormone. Thus it may be easier to maintain a certain level 
of steroid in the blood using smaller doses rather than massive doses of 
the steroid. From this standpoint~ it may be advantageous to give one or 
two massive doses to bring the steroid content in the tissues up quickly, 
followed by periodic injections of small doses of the hormone to maintain 
the level in the tissue where absorption takes place. 
The fact that steroids were being excreted in the urine concomitant 
with a rise in steroids in the plasma indicates that the rise in free 
steroids in the plasma was not due to protein binding. If the steroids 
in the plasma were protein bound, the free steroids in the urine would 
have decreased (20, 106). 
The fact that the steroid levels in the plasma and urine did not 
return innnediately to the preinjection level after injections were stopped 
indicates a slow absorption of the steroid from the tissues. This is also 
evident in the slow rise in free steroids in plasma and urine after injec-
tions were started. Holtz (57) has reported on the slow rate of absorp-
tion of testosterone after a large single injection. He reported the 
presence of testosterone metabolites in the urine three months following: 
the injection. If this period of time were added to the time when injec-
tions were stopped in this experiment, the date would be about December 7. 
!'his date corresponds quite closely with the time when the plasma and 
urinary steroid content reached a minimum. Therefore) it would appear 
that most of the injected steroid had been absorbed from the tissues 
61 
during this three-month period. Judging from the urinary excretion, the 
steroid probably was almost entirely absorbed by November 24. 
There is a possibility that the hot weather during the summer months 
could have lowered the thyroxine secretion rate thereby decreasing the 
rate of conjugation and metabolism of testosterone (85). This would 
explain the marked increase in steroid content in the plasma after June 23, 
1958. This possibility should be considered since it has been shown that 
thyroxine increases total hepatic activity for in vitro ring A reduction 
of cortisol (145). It also accelerates the maturation of the glucuronosyl 
transferase system in young animals (138). The data from this experiment 
correlate well with the findings of Robertson and McGregor (101) who 
observed a decreased excretion of steroids in the urine during sunnner 
months. This mechanism might explain why there is a tendency for some 
farm animals to experience a temporary infertility during hot summer months. 
Through this mechanism a decreased thyroxine secretion would increase the 
testosterone level in the blood which in turn would decrease FSH and LH 
production by the pituitary. Due to the decreased secretion of these two 
gonadotrophic hormones, spermatogenesis could be interrupted during hot 
weather. There is, however, another possibility to consider. This would 
be through a cellular action whereby thyroxine augments or potentiates 
the action of these two gonadotrophic hormones. Thus, an increased 
response would be noted in the winter and a decreased response during the 
hot summer months (85). 
The reason for the fact that the plasma level of free (INH) steroids 
almost reached the preinjection level on October 27 then rose to a new peak 
on December 8 is not known. However, it probably reflected endogenous 
secretion and metabolism. There is a possibility that the thyroid may 
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have been implicated in the response noted here since this time of year 
was characterized by cooler weather. This cooler weather could have 
induced an increased thyroxine secretion which in turn would have 
increased the rate of steroid metabolism, thereby tending to flush the 
steroids from the bloodstream. This would be consistent with the data 
reported by Robinson and McGregor (101) who reported an increased urinary 
secretion of steroids in sheep during the cold, winter months. Although 
the free (!NH) steroids in the plasma decreased during this period of 
time, thyroxine could have potentiated the action of the surviving 
testosterone or the pitui tary gonadotrophins. This potentiating action 
of thyroxine would help explain the observed response in respect to 
testicular volume which increased during this period of time. The same 
reasoning would apply also to the spermatozoa per ejaculate which increased 
during this period of time. This reasoning does not, however, explain the 
tremendous increase in conjugated, !NH steroids in the plasma (Figure 1). 
This period of time would also be characterized by an increased intake 
of feed; however, this increased feed consumption would not be able to 
account for the three-fold increase in total (INH) steroid content of the 
plasma. Since the feed .was given ad libitum, the total dry-matter excreted 
was calcu lated from the data to see if the fecal dry-matter would reflect 
any gross changes in feed consumption (Figure 13). Although a consider-
able variation was experienced throughout the experiment, no definite 
trend could be established in connection with seasons of the year. There 
was, however , a slight overall increase in the dry-matter content of the 
feces during the experiment. This overall increase in dry-matter excre-
tion reflects an increased size of the bulls with a corresponding increa se 
in the maintenance requirements for these animals. 
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Unfortunately the INH test was not employed on all of the samples 
throughout the t ·cial. It wou ld have been much better had the INH test 
been used on the plasma samples throughout all of the control period; 
however, it was used to see if it could be of use in following exogenous 
steroid metabolism in the ruminant. This question was answered in the 
affirmative. Nevertheless, the !NH test should be evaluated in terms of 
its specificity in order to evaluate its usefulness as a tool in evaluat-
ing steroid metabolism in the ruminant. More information could be gained 
when using the INH test if the crude extract were purified using column 
and paper chromatography. 
Some General Aspects of Ionone Metabolism in Bulls 
Inspection of Figures 1 through 10 shows that the fecal steroids 
were high at the beginning of the experiment with a continual drop 
throughout the experiment. The only exception to this observation was 
during the period from October 13, 1958 to February 16, 1959. This 
decrease in steroid content was evident in spite of a general increase 
in fecal dry-matter content (Figure 13). Since the INH test measures 
predominantly 64-3-ketosteroids or compounds with a double bond conjugated 
with a carbonyl group, it was suspected that perhaps the liver or bac-
teria in the digestive tract were involved in metabolizing compounds 
of this nature occurring in the digestive tract. 4 That the 6 -3-keto-
steroids or similar materials were being reduced so as not to give a 
positive test with the INH procedure is quite evident in Figure 8. Here 
the urinary extract was separated into 17-ketosteroid and 17-hydroxy-
corticosteroid fractions using column chromatography. The resulting 
17-ketosteroid fractions were split and analyzed by both Zinmierman and 
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INH procedures. During the control period, the two values were almost 
identical. However, the differences obtained by use of the two methods 
progressively increased throughout the experiment. This indicated that 
compounds with the double bond conjugated with a carbonyl group were 
disappearing and reappearing as a reduced compound that did not give a 
positive INH test. To support further this observation, a similar 
decline in 17-hydroxycorticosteroids was observed in the feces (Figure 
10). Since this fraction was assayed using the INH procedure, it would 
appear that some of this !NH-positive material was disappearing due 
probably to metabolism. Similarl~ the urinary extract was separated into 
17-ketosteroid and 17-hydroxycorticosteroid fractions using column 
chromatography. The resulting 17-ketosteroid fraction was split and 
assayed using both the INH and Zimmerman reactions. Here again (Figure 
8) a general increase in the 17-ketosteroid Zimmerman positive materials 
can be seen with very little change in the 17-ketosteroid !NH-positive 
materials. 
It is of interest to note that all the free, glucuronide, sulfate, 
and total, fecal, !NH-positive materials declined throughout the experi-
ment. This would indicate that the compounds were capable of being 
conjugated with either glucur onic acid or sulfate. It has been shown 
that all of the known steroids except testosterone and estrogen are 
conjugated at the three posi tion after the ~4-3-keto group has been 
reduced to the corresponding tetrahydro derivative (10, 111, 141). It 
also has been implied that urinary and biliary losses of metabolically 
active steroids are, under normal conditions, negligible (131). This 
would i ndicate that the material being metabolized was of dietary origin 
and probably not a steroid. Of the ionone derivatives isolated from cattle 
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urine by Holtz (57), only two compounds (ketone Kand ketone J) would give 
a positive test under the requirements listed by Weichselbaum and Margraf 
(134). However, it is possible that there are other plant steroids which 
could be metabolized, as ketone Kand ketone J could be metabolized, to 
the tetrahydro derivatives giving the observed results. Other plant 
steroids could have been present in the crude extract since Ungar and 
Dorfman (130) have shown that the Porter-Silber values from calf urine 
decreased by about 88 per cent after column and paper chrow~tography. 
Thus, it would appear that there were in this experiment materials of 
plant origin capable of being metabolized and conjugated with glucuronic 
acid or sulfate. Furthermore, it would appear that there was an age 
factor as far as the ability to metabolize these compounds were concerned. 
It would appear that the ability of the animal to reduce these compounds 
increased with age. 
Since the free, !NH-positive chromogens in the feces declined at a 
rate similar to that for glucuronide and sulfate-conjugated fractions 
(Figure 3), it would appear that the precursors for all three fractions 
were being metabolized at a similar rate. A proposed metabolic scheme for 
the metabolism of ionone derivatives can be found in Figure 14. The 
structures of the compounds used in this scheme are based on the structures 
of compounds previously isolated from cattle urine (57) . I t should be 
kept in mind that these compounds, in all probability, do not give a 
positive test with the Porter-Silber reaction. Therefore, this proposed 
scheme was not intended to be used to explain the results observed by 
Ungar and Dorfman (130) in regard to the decrease in Porter-Silber posi·· 
tive materials following column and paper chromatography. 
y 
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Diketone D 
HO 
Hydroxyketone G 
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Ketone J Dihydroxketone J Tetrahydroketone J 
1 
OB 2 Hydroxyketone C 
/ 
Hypothetical structure similar to hydroxyketone C except for a double 
bond. ··· - - ····· · 
2 The structure of this compound not fully established at present (32). 
Figure 14. Proposed Schemes . for the Metabolism of Ionone 
Derivatives in the Ruminant 
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If a double bond conjugated with a carbonyl group is required for a 
positive INH test, only ketone Kand ketone J would be expected to give 
a color with the INH reagent (Figure 14). However, the Zimmerman test 
requires a -CH2co- grouping (carbonyl group) for a positive test (9). Of 
the compounds listed in Figure 14, only the following would give a posi-
tive test with this method: ketone K, hydroxyketone, diketone D, hydroxy-
ketone E, hydroxyketone G, ketone J, dihydroketone J, and hydroxyketone C. 
In this proposed scheme, only hydroxyketone, dihydroketone J, and tetra-
hydroketone J are theoretical compounds used to explain the observed 
results. It should be kept in mind that the other compounds in these 
schemes have been isolated and fully characterized. Other compounds did 
exist in the urine extracts of Holtz (57) which were not fully character-
ized or identified. 
The decrease in !NH-positive chromogens in the feces in the free form 
could well be attributed to ketone Kor ketone J. These two compounds may 
have been present in the plasma and urine as well. The 2.5 pgm. per ml. 
of free, !NH-positive materials in the urine at the start of the experiment 
(Table I) could be due to these compounds. If these two compounds were 
not readily resorbed·· from the kidney tubules, this would explain in part 
why the free (INH) chromogens in the plasma on April 28, 1959 were so low 
(0.13 ugm. per ml. of plasma). If ring B of ketone K were opened, this 
could, through a series of reductive steps, give rise to diketone D and 
hydroxyketone. Similarly, ketone J could be reduced to dihydroketone J. 
These three compounds (diketone D, hydroxyketone, and dihydroketone J) 
would be capable of giving a positive !NH test. This would explain the 
increase in 17-ketosteroids (Zimmerman) concomitant with a decrease in 
17-ketosteroid (!NH) in the feces. Since a large portion of the !NH-
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positive chromogens in the feces were conjugated with either glucuronic 
acid or sulfate, it would require a compound with a structure similar to 
hydroxyketone to explain the positive INH test and the ability to be 
conjugated. This compound must have a -OH group for conjugation and a 
double bond conjugated with a carbonyl group for a positive INH test. 
Hydroxyketone would fulfill these requirements. 
Both hydroxyketone E and hydroxyketone G have been isolated from 
cattle urine; therefore, it would be probable that hydroxyketone E could 
be formed through reduction of hydroxyketone. Similarly, hydroxyketone 
G could be formed through reduction of diketone D. In addition, it would 
be possible for hydroxyketone E to be formed from hydroxyketone G through 
a reversible enzyme catalyzed reaction. Nevertheless, both of these two 
compounds would give a positive Zimmerman test, but not a positive !NH 
test. The formation of these two compounds help to explain the increase 
in 17-ketosteroid (Zimmerman-positive) chromogens in the feces during the 
time when the 17-ketosteroid (!NH-positive) chromogens were decreasing in 
the feces. It should be remembered that most of these compounds, includ-
ing diol A and tetrahydroketone J, could be conjugated even though the 
latter two would not be detected using either the Zimmerman or !NH test. 
As stated earlier, the only three not capable of being conjugated are 
ketone K, diketone D, and ketone J~ 
Considering these chemical configurations and proposed metabolic 
schemes, it is highly probable that the decrease in !NH-positive materials 
in the feces during the experiment was due to the metabolic changes of 
these compounds. Since the ionone derivatives account for roughly 90 
per cent of the urinary 17 -ketosteroid (Zimmerman) chromogens (57, 130), 
the question arises as what affect these compounds might have on steroid 
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metabolism. Since these compounds have a structure similar to the isoprene 
nucleus of steroids, it is highly probable that the ionone derivatives could 
be accounted for by similar mechanism for steroids. If these compounds 
are reduced with TPNH as are the steroids (131), how much affect can these 
ionone derivatives have on TPNH availability in the liver cell? It has 
been postulated that under normal conditions, the reduction of the 64-3-
keto grouping is the rate-limiting step in the metabolism and excretion of 
many steroids (121, 131, 145). If this is true and if the ionone deriva-
tives are metabolized by the same enzyme mechanism, a very significant 
alteration in the rate of metabolism of these steroids could result from 
sudden appearance of these compounds in the blood from the diet. 
Since there are other compounds such as testosterone, thyroxine, 
estrogens, etc . that are not reduced before conjugation, it is highly 
probable that a substrate competition for UDPGA and PAPS could exist. 
In this respect, it has been shown that following injections of estrogen, 
the disappearance rates of various steroids including tetrahydrocortisone 
were altered within a matter of minutes (11, 30, 42, 51, 98, 133). This 
would tend to rule out protein binding as the only causative agent in 
decreasing the removal time of these compounds. It has also been shown 
that n-acetyl-p-aninophenol increased the plasma 17-hydroxycorticosteroid 
level s when given in connection with cortisol and prednisolone (17). This 
effect was presumed to be due to inhibited steroid-glucuronide format ion 
in the liver. It also was shown that this compound increased conjugated 
glucuronic acid in the urine (16) . This increase in glucuronic acid was 
due primarily to the glucuronide of n-acetyl-p-aminophenol. 
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Plasma Steroid Levels 
Unfortunately, very few studies have been conducted on the steroid 
levels in the blood of ruminants. Meschanks (77) has reported low levels 
of sex steroids in blood using bioassays while Robertson and Mixner (100), 
Robertson et al. (99), and Shaw et al. (114) have reported low 17-hydroxy-
corticosteroid levels in the blood of cattle. These workers have reported 
17-hydroxycorticosteroid values of about 5 pgm. per 100 ml. of plasma. 
The values found during this investigation were considerably lower than 
these values which were around 1-2;ugm. per 100 ml. of plasma. Although 
very little information is available in the literature concerning 17-keto-
steroid values, the values obtained during this investigation were found 
to be low in contrast to humans but higher than the 17-hydroxycortico-
steroid (Porter-Silber) obtained during this experiment. The extreme high 
for the entire experimental period was a mean value of 379 pgm. per 100 
ml. on June 23, 1958. 
The question arises as to why the values are so much lower for 
ruminants than they are for non-ruminants. Do the ionone derivatives 
have any influence on the steroid levels in the blood? This is only one 
of the many questions that need to be answered as far as steroid metab-
olism in the ruminant is concerned. 
It is of interest to note that the glucuronide and sulfate-conjugated 
steroids in the plasma (!NH) are about equal at the beginning of the experi-
ment (Figure 1) . These values seem to fluctuate back and forth as far as 
which one predominated as the main fraction during the experiment. When 
the experiment was terminated, ther e were three times as much glucuronide-
conjugated as there were sulfate-conjugated materials. 
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Urinary Steroid Excretion 
Holm and Firch (55) have reported an average of 18.4 mg. per liter of 
glucuronide-conjugated 17-ketosteroids (Zimmerman) and an average of 21.0 
mg. per liter of free 17-ketosteroids (Zimmerman) for six cows. This 
would correspond to an average of 39.4 mg. of total 17-ketosteroids 
(Zimmerman) per liter. Meschanks (77) reported a mean of 22.0 mg. of 
total 17-ketosteroids (Zimmerman) per liter for bulls and 16.0 mg. per 
liter for cows. 
The 17-ketosteroid (Zimmerman) excretion on April 28, 1958 of this 
experiment was found to be 19.3 mg. per liter. However, this fraction 
contained only the free and glucuronide-conjugated steroids since~-
glucuronidase instead of hot HCL was used to hydrolyze the bound steroids. 
Other values for the urine during the preliminary period were within the 
range of values reported by these two groups. 
It is of interest to note that the urinary steroid levels did not, 
for the most part, reflect gross changes in steroid metabolism which would 
have been expected during the period of injection of testosterone. Since 
the 17-ketosteroids (Zimmerman) increased throughout the experiment, it 
would appear useless to compare given periods of time with amounts of 
steroids excreted in the urine since the age affect and the change in 
metabolism of ionone derivatives might overshaddow any real change in 
steroid metabolism. There is also the possibility that a misinterpreta-
tion of the data might result from the age effect. 
Fecal Steroid Excretion 
Total steroid excretion per day (Table III) was calculated from the 
data for the last day of collect ion for each period; namely, April 28, 1958, 
TABLE III. AVERAGE DAILY EXCRETION OF VARIOUS STEROID 
FRACTIONS TAKEN FROM THE LAST COLLECTION PERIOD 
OF THREE EXPERIMENTAL PERIODS* 
Dates 
Steroid Fractions 4-28-58 9- 1-58 
(mg.) (mg.) 
Urine (INH) Free 12.3 24.9 
Gluc. 45.0 17.4 
S04 54.5 51.5 
Total 111.8 93.8 
Feces (INH) Free 262.5 197.4 
Gluc. 226.8 85.0 
S04 153.4 112. 2 
Total 642.7 394.5 
Urine (Zimm.) 17 -Keto. 89.0 149.0 
Urine (INH) 17 -Keto. 37.2 36.4 
Urine (INH) 17-0HCS 3.0 2.2 
Feces (Zimm.) 17-Keto. 615.2 671.6 
Feces (INH) 17-Keto. 520.5 293.6 
Feces ( I NH) 17-0HCS 113.4 42.6 
72 
4-27-59 
(mg.) 
41.1 
32.0 
87.4 
160.5 
108.5 
137.0 
194.9 
440.4 
246.3 
62.1 
5.3 
626.2 
296.7 
40.4 
* Values calculated for the number obtained if all six samples were 
not collected. 
TABLE IV. FECAL:URINARY RATIOS OF EXCRETED STEROIDS USING AVERAGE 
DAILY EXCRETION VAUJES OF VARIOUS ASSAYS TAKEN ON THE LAST 
COLLECTION PERIOD OF THREE EXPERIMENTAL PERIODS 
Dates 
Steroid Fractions 4-28-58 9-1-58 4-27-59 
(mg.) (mg.) (mg.) 
Total (INH) 5. 75 4.20 2. 74 
17-Keto. (Zimm.) 6.91 4.51 2.54 
17-Keto. (!NH) 13.99 8.06 4.78 
17-0HCS (INH) 37.80 19.36 7.62 
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August 1, 1958, and April 27, 1959. This was done for comparative purposes. 
In rodents, biliary excretion predominates while in many only small amounts 
of steroids are excreted in the feces (39). Biliary excretion in ruminants 
has been said to be more important than the urinary route (53, 55, 79, 81, 
100, 130). The data obtained from this experiment substantiate these 
claims (Tables II, III, and IV). In Table IV, the fecal urine ratios were 
calculated for the three representative days April 28, 1958, September 1, 
1958, and April 27, 1959. In all cases the fecal elimination exceeded the 
urinary elimination. There were differences in sepcific steroid fractions 
as to the preferred route of excretion. There also appears to be a specific 
age effect as to the specific route of elimination. The 17-hydroxycortico-
steroids (INH) were more predominantly excreted in the feces followed by 
17-ketosteroids (INH), 17-ketosteroids (Zimmerman), and total (INH) 
steroids in decreasing order. It is of interest to note that the total 
(INH) and 17-ketosteroids (Zimmerman) parallel each other very closely 
during the three observation periods listed. 
On comparing the excretion of fecal steroids in Figures 9 and 10, an 
overall decrease in steroid excretion was observed. This overall decrease 
in excretion was undoubtedly due to the metabolism of ionone derivatives 
as mentioned earlier. Some of these derivatives may be metabolized to the 
point where they no longer give a positve test with either the Zimmerman 
or !NH method. Such a compound would be Diol A (Figure 14) which is known 
to be conjugated. No noticeable change was observed in the urinary excr e-
tion during the period from December 8, 1959 to April 30, 1959 (Figures 
5, 6, and 7). The plasma levels of !NH positive conjugated materials rose 
t o tremendous heights during this period of time. There was also a signif -
icant change in the fecal excretion during this period. 
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It has been shown in humans that up to 90 per cent of the free 
steroids in the urine was resorbed, whereas the glucuronide conjugated 
steroids were not resorbed. If this were true in cattle, then a rise in 
the conjugated steroids should have occurred in the urine during this 
period of time. This was not the case. The only apparent explanation 
that could explain this observation would be an increase in protein bind-
ing of the conjugated materials. The conjugates of steroids are known 
to be protein bound in plasma (117). However, if this situation were 
present, then the levels in the feces should also be correspondingly low. 
This was not the case in this experiment. If, on the other hand, a pump 
mechanism is present in the kidney tubules for resorption of the conjug-
ated steroids, this could account for the failure to observe a rise of 
these compounds in the urine. Since the conjugated materials, as well as 
the free materials, were found to be predominantly excreted by the feces, 
a pump mechanism in the liver biliary duct cells must be present. If 
this pump mechanism is more specific for some compounds than others, then 
the piling up in the plasma could be attributed to a competition of sub-
strates for the pump mechanims. It should be kept in mind that this 
period was also characterized by cold weather which would have increased 
the circulating l evel of thyroxine. This increase of thyroxine must be 
handled by the liver also. Other compounds whih do not give a positive 
test with either the INH or Zinnnerman methods could also be present giving 
rise to further competition. Not being excreted, these compounds would 
build up in the plasma until such time as they could be excreted. 
When comparing the data in Figures 5, 6, and 7, the conjugated 
materials in the feces were found to be lowest (January 5, 1959) when the 
conjugated material reached a peak in the plasma. As the level of 
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conjugated material in the plasma dropped, the fecal content increased. 
It cannot be argued that a depressed liver function in all of the 
animals was present during this period of time and thereby accounting for 
the observed results since there were low plasma levels of free !NH 
materials at this time (Figure 4). 
It is interesting to note that in the studies reported by Ungar and 
Dorfman (130) about 90 per cent of the 17-hydroxycorticosteroids (Porter-
Silber) and 17-ketosteroids (Zimmerman) were ionone derivatives. Even 
though most of the ionone derivatives were removed by column and paper 
chromatography, the purified steroid fractions still reflected many of 
the gross variations present in the crude extract. Thus, it may be con-
cluded that even though the ionone derivatives may not be metabolically 
active, they may have a pronounced effect on hormone metabolism. 
Inspection of the various steroid fractions from individual animals 
indicates that each animal has its own characteristic excretion pattern. 
However, it was hoped that by pooling the data from six animals, the 
fluctuations of one animal would be offset by those of other animals so 
that the mean values would be meaningful in evaluating steroid metabolism 
in the ruminant. This was accomplished with a moderate degree of success. 
PART II: 
Conjugation of Steroids by the Liver 
In Part I of these experiments a tremendous amount of steroids and 
ionone derivatives were found in the conjugated state. Most of these 
conjugates were found i n the feces and urine as excretory products. Thus 
it seemed advisabl e to inves tigate the nature of the glucuronosyl 
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transferase system in the liver of the ruminant. Sheep were used in these 
exper i ments for economic reasons and ease of handling. 
Initial studies were undertaken in the sheep and the dog; however, 
these studies were temporarily abandoned due to technical difficulties 
which were later worked out in the rat. After working out these diffi-
culties, studies were conducted on the three species. Since the dog and 
rat are no t ruminants and were not fed diet s high in carot enoids , t his 
pr esented the possibility of comparing the glucuronosyl transferase 
activity of these three species. 
There are, however, two parameters to consider when evaluating 
transferase activity of a given tissue; the rate of synthesis of UDPGA 
and the amount of transferase activity in the tissue in question. In 
order to evaluate the first parameter, homogenates of the tissue were 
prepared and assayed as described earlier. In the tissue homogenates, 
the enzymes for synthesis of UDPGA were present as well as the transferase 
enzyme. In these studies, UDPGA was added in catalytic amounts (50..,Algm.) 
so that UDPGA would be the rate-limiting factor in the overall synthesis 
of steroid-glucuronides. 
The second parameter was evaluated using microsomal preparations and 
l a rger quantities of UDPGA (0.4.,uMoles) so that the rate of synthesis of 
glucuroni des would be related to transferase activity instead of UDPGA 
synthesis. 
The data from these assays are recorded in Table V for homogenates 
and Table VI for microsoma l prepar a t ions. From the data in Table V it 
can be seen that the amount of s t eroid disappearing upon incubation and 
reappearing a fter ~-glucuronidas e hydrolysis is greatest for the sheep 
liver. This is consistent with the findings in Part I where it was found 
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that these ruminants had tremendous amounts of materials in the urine 
and feces which were apparently conjugated by the animal. Therefore, the 
liver of the ruminant rather than that of the dog or rat would be expected 
to have the greatest abili ty to synthesize UDPGA for the conjugation of 
steroids and ionone derivatives. 
In preliminary studies designed to expand upon this previous observa-
tion, glucose and galactose were assayed with sheep liver homogenate to 
see which would be mos t effective in the production of UDPGA since it 
has been shown that galactose is a better precursor for glucuronic acid 
synthesis than glucose (126). The results from this study indicated that 
glucose was a much better precursor than galactose. This is as would be 
expected since the ruminant probably does not metabolize as much 
galactose as it does glucose. When glucose was used as the substrate, 
0.040J1Moles of phenolphthalein disappeared in contrast to 0.020.JlMoles 
of indicator which disappeared when galactose was used as the subsrate 
for UDPGA synthesis. When p-nitrophenol was being conjugated, 0.041 
pMoles of the dye disappeared on incubation with glucose in contrast to 
0.034J1Moles of dye which disappeared when galactose was used as the 
precursor for UDPGA synthesis. 
A comparison of the data in Table VI shows that sheep liver had the 
greatest transferase activity based on the amount of steroid disappear-
ing on incubation and reappearing on hydrolysis with ~-glucuronidase. It 
can also be seen that the ovine liver conjugates both H4E and H4F t o 
approximately the same extent . In this respect, it is interesting to note 
that Glick (39) has isolated both H4E and H4F from bile of cattle a fter 
~-glucuronidase hydro lysis. From the data in Tables V and VI it also can 
be seen that the steroid recover ed after ~- glucuronidase hydrolysis was 
TABLE V. GLUCURONIDE CONJUGATION OF VARIOUS SUBSTRATES 
USING HOMOGENATES OF LIVER AND ADRENAL TISSUES 
FROM SHEEP, DOG, AND RAT 
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Substrate Substrate 
Number of Disappearing Recovered as 
Animal Tissue Substrate Observations On Incubation Glucuronide 
Sheep 
Sheep 
Dog 
Dog 
Rat 
Rat 
Rat 
Liver 
Adrenal 
Liver 
Adrenal 
Liver 
Liver 
Adrenal 
H4E 
H4E 
H4E 
H4E 
H4E 
H4F 
H4E 
10 
10 
5 
5 
5 
5 
4 
(pMoles) 
0 .101 + .025* 
0 .032 + .006* 
(pMoles) 
0.047 + .017* 
0. 008 + .008* 
0.038 + .012* (-)0.005 :!:. .003* 
0.065 :!:. .003* (-)0.003 :!:. .001* 
0.073 + .022* 0. 009 + .005* 
0 .012 + .007* 0 .005 + .004** 
0 .040 + .019* 0. 004 + .001* 
1 Denotes the amount of substrate in pMoles followed by the S.D. and 
statistical Probability. 
* Denotes a statistical Probability< 0.05 as compared with non-
incubated controls. 
** Denotes a statistical Probability< 0.10 as compared with non-
incubated controls. 
TABLE VI. GLUCURONIDE CONJUGATION OF VARIOUS SUBSTRATES USING 
MICROSOMAL PREPARATIONS OF LIVER AND ADRENAL 
TISSUES FROM VARIOUS ANIMALS 
Substrate 
Number of Disappearing 
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Animal Tissue Substrate Observations On Incubation 
Substrate 
Recovered as 
Glucuronide 
Sheep 
Sheep 
Sheep 
Sheep 
Sheep 
Dog 
Dog 
Dog 
Dog 
Rat 
Rat 
Rat 
1 
Liver 
Liver 
Liver 
Liver 
Adrenal 
Liver 
Liver 
Liver 
Adrenal 
Liver 
Liver 
Liver 
1 (µMoles) (µMoles) 
5 0.178 + .006* 0.092 + .003* 
5 0. 126 + . 023* 0 .104 + .058* 
2 Phenolphtha. 5 
3 p-NP 
H4E 
5 
5 
5 H4E 
Phenolphtha. 5 
p-NP 5 
5 H4E 
Phenolphtha. 5 
p-NP 5 
0 .184 + .049* 
0 .140 + .028* 
0.006 + .003** 0.002 + .002* 
0.040 + .007* 0.0002 + .0001** 
0 .072 + .015* 
0 .063 + .017* 
0.051 + .022* (-)0.0004 ±. .0002** 
0 . 0 2 5 + . 015* 0.006 + .003* 
0.028 + .015* 
0 .020 + .007* 
Denotes the amount of substrate inpMoles followed by the S.D. and 
statistical Probability. 
2Phenolphthalein. 
\-Nitrophenol. 
* Denotes a statistical Probab i lity< 0.05 as compared with non-
incubated controls. 
** Denotes a statistical Probability< 0.10 as compared with non-
incubated controls. 
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was always lower than the amount of steroid disappearing upon incubation. 
This difference could be due to the failure to hydrolyze all of the steroid-
glucuronides formed during incubation or it could be due to metabolism of 
the steroid to a derivative that no longer gives a positive test with the 
Porter-Silber reaction. Metabolism of the steroid could be accomplished 
through reduction of the side chai n or through cleavage of the side chain 
to give the corresponding 17-ketosteroid. That metabolism of ,the steroid 
molecules took place during these incubations is highly probable since 
the enzymes for the metabolism of the steroids are found in microsomal 
fractions of disrupted cells. (96). 
The problems of quantitatively assaying for glucuronosyl transferase 
activity are many. One of the biggest problems lies in the fact that 
many competing enzyme reactions occur simultaneously during the incubation 
period. These reactions have been summarized in Figure 15. It has been 
shown by Pogell and Krisman (91) that a pyrophosphatase exists in skin 
extracts which rapidly destroys UDPGA to form UMP and glucuronic acid-1-
phosphate. The UMP and glucuronic-1-phosphate are broken down further to 
glucuronic acid, uridine, and phosphate by a phosphatase. In addition, 
DeDuve et al. (22) have demonstrated the presence of ~-glucuronidase in 
microsomal fractions of disrupted cells. This enzyme was attributed t o 
the lysosome, a particu late fraction of the cell which contains many 
hydrolytic enzymes. Other enzymes iso lated from this structural entity 
of the cell are phosphatase and sulfatase. Therefore, any glucuronide 
formed during incubation could be hydrolyzed and the UDP destroyed so 
that no net synthes i s of steroid wou ld result. These same observations 
have been extended t o the rat liver mi crosomal preparations with all of 
the competing reactions t aking place (92). 
Glucose-1-phosphate 
I (Trans f erase) 
l 
Glucuronic acid+ Phosphate UDPGlucose Steroid+ Glucuronic acid 
(Phoslatase) (DehydLgenase) ( f!-gluculnidase) 
Glucuronic jid-1-phosphate ~ (Pyrophos-) __ UDLA + ( Glucuronosy 1) steroid _j lucuronide 
+ UMP (phatases) Phenol--(transferase > + UDP 
I I (Phosphatase) (Phosphatase) 
Uridine + thospbate Uridine + 12 Phosphate 
* 
Figure 15. Competing Reactions in Rat Liver for Synthesis, 
Transfer, and Degradation of UDPGA* 
Based on the findings of Pogell and Leloir (92). 
00 
I-' 
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It has been shown in preliminary studies in connection with this 
present series of experiments that UDP assays failed to correspond to 
either the amount of steroid disappearing on incubation or the amount of 
steroid liberated after hydrolysis with t:3-glucuronidase. Therefore, UDP 
assays were not run on the experiments reported in Tables V and VI. 
Furthermore, glucuronic acid production was observed with rat liver homo-
genates and electrophoretic separation of the compounds formed after 
incubation. Electrophoretic separations were accomplished according to 
the method of Cohn and Bondy (15). Using these electrophoretograms, the 
presence of a sulfatase also was demonstrated. These electrophoretograms 
also were used to confirm the fact that the steroids reappearing after 
hydrolysis with ~-glucuronidase were, in fact, true conjugates and not 
artifacts. 
Of particular interest is the apparent lack of conjugation of steroids 
in dog liver and adrenal preparations. Many attempts were made to demon-
strate transferase in liver and adrenal tissues from this animal. Various 
buffer combinations as well as incubation procedures were used without 
success; however, a positive assay was obtained for phenolphthalein and 
p-nitrophenol. That steroid conjugation does take place in dog liver is 
evident from indirect methods reported in the literature (14, 65). 
Willoughby et al. (139) have shown that the rate of removal of c14-labeled 
corticosterone from plas~~ was clearly reduced in hepatectomized dogs. 
Therefore, the negative results obtained with dog liver and adrenal 
tissues are undoubtably due t o t he pr esence of competing r eactions which 
either destroy the UDPGA so fa s t that conjugates cannot be formed or that 
t he product is hydrolyzed after being formed. The latter explanation is 
highly probable since a decrease of endogenously conjugated steroids 
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was observed in the glucuronide fraction after incubation. Thus there 
is good reason to believe that there was present in these dog liver and 
adrenal homogenates and microsomal preparations a ~-glucuronidase which 
hydrolyzed the glucuronides as fast as they were formed (Tables V and VI). 
The positive assay for conjugation of phenolphthalein and p-nitrophenol 
probably was due to a substrate specificity for the ~-glucuronidase 
resulting in less destruction of the newly formed conjugates of these two 
dyes than for the steroid. The possibility does exist that the enzyme 
activity in the dog liver is greater for these dyes than for steroids 
since it has been shown that considerable in vivo conjugation of steroids 
takes place in the kidney of this animal. 
Conjugation of Steroids by the Adrenal 
In Part I it was shown that there were many compounds present in the 
urine and feces in the conjugated state. Since these compounds are true 
excretory products having been detoxified by the animal, the presence of 
these compounds in the blood would pose a tremendous burden for the liver 
to conjugate them all before excretion. Therefore, it seemed probable that 
other organs may participate in steroid conjugation besides the liver. 
The adrenal gland was suspected of being able to conjugate steroids since 
Newcomer and Heninger (87) have put forth evidence for glucuronosyl trans-
ferase activity in the avian adrenal. 
Homogenate and microsomal preparations were assayed for UDPGA synthe-
sis and glucuronosyl transferase activity as previously outlined. Rat 
adrenal microsomal preparat i ons were not used in this study because of 
t he failure to obtain enough adrenal microsomes to complete an assay. 
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Several attempts were made to prepare microsomes from this tissue without 
success. 
Inspection of the data in Tables V and VI shows that only the sheep 
adrenal and rat adrenal homogenates were capable of demonstrating a net 
synthesis of steroid-conjugates. In the case of the dog homogenate, the 
presence of ~-glucuronidase could have prevented a positive assay. It 
also is quite likely that this reaction as well as the other competing 
reactions mentioned earlier (Figure 15) prevented the demonstration of 
glucuronosyl transferase activity using microsomal preparations from the 
sheep and dog. These data also show that the sheep liver had the greatest 
ability to synthesize UDPGA as well as the greatest transferase activity. 
The role of tissues other than the liver in the overall conjugation 
of steroids is not known at present. However, it is not likely that the 
conjugation of steroids could be a mechanism in the process of steroid 
secretion since most of the steroids in the gland were in the free form 
with very small amounts of endogenous steroid-glucuronides being present. 
In this connection, it has been shown in human adrenal perfusion studies 
that the venous blood collected from the perfused adrenals contained the 
same amount of conjugated steroids as arterial blood. Furthermore, it 
has been shown in the rat that only small amounts of steroid were conjug-
ated after removal of the liver, digestive tract, and spleen (5). 
Although in vitro conjugation of steroids has been observed in skin 
(122), digestive tract (43, 45, 122), kidney ( 14, 67), spleen (67), liver 
(25) , and adrenal (87), very l itt le is known concer ning the intracellular 
compartmentalization and metabolic control of the conjugation systems in 
these tissues and t heir rela tionshi p with other metabolic pathways. This 
pMoles of 
Substrate 
Added 
0.0 
0.1 
0.2 
0.3 
0.4 
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TABLE VII. DATA FROM INHIBITION STUDIES USING SHEEP 
LIVER MICROSOMAL PREPARATION, PHENOLPHTHALEIN AS 
THE SUBSTRATE, AND H4E AS THE INHIBITOR 
pMoles of 
Substrate 
Disappearing 
on Incubation 
(No Inhibitor) 
0.000 
0.076 
0.146 
0.231 
0.294 
pMoles of 
Substrate 
Disappearing 
on Incubation 
(Inhibitor Added) 
0.000 
0 . 070 
0.142 
0.195 
0.232 
TABLE VIII. DATA FROM INHIBITION STUDIES USING SHEEP LIVER 
MICROSOMAL PREPARATION, p-NITROPHENOL AS THE 
SUBSTRATE, AND H4E AS THE INHIBITOR 
,,uMoles of 
Substrate 
Added 
0.0 
0.1 
0.2 
0.3 
0 . 4 
pMoles of 
Substrate 
Disappearing 
on Incubation 
(No Inhibitor) 
0.000 
0.055 
0.135 
0.200 
0 . 269 
)lMoles of 
Substrate 
Disappearing 
on Incubation 
(Inhibitor Added) 
0.000 
0.046 
0.125 
0.168 
0.187 
0.4 
0.3 
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is especially true of the ruminant where some 90 per cent of the steroid 
fractions is comprised of ionone derivatives from the feed. 
Inhibition Studies 
An attempt was made to evaluate the conjugation mechanism of the 
sheep liver to see if a substrate competition could be present. The 
substrates being measured were phenolphthalein and p-nitrophenol; the 
inhibitor was H4E. The data from these experiments are recorded in Table 
VII for phenolphthalein and Table VIII for p-nitrophenol. An attempt was 
made to analyze the data using Lineweaver-Burk plots (23), The plots did 
not readily reveal the nature of the competition. The velocity vs sub-
strate concentration plots in Figures 16 and 17 did, however, resemble 
what Dixon and Webb (23) refer to as mixed competition. Therefore, 
these experiments should be re-evaluated using inhibitors to block the 
competing reactions mentioned earlier (Figure 15). 
SUMMARY AND CONCLUSIONS 
In Part I of the thesis, steroid metabolism was followed in six, 
Hereford,range bulls over a 69-week period using the INH, Zimmet1I12n, 
and Porter-Silber reactions. This 69-week experimental period was sub-
divided into a 17-week control period, an 18-week injection period, and 
a 34-week recovery period. Samples of plasma, urine, and feces, col lected 
every other week throughout the experiment, were prepared for analysis 
using various fractionation procedures. These data were compared with 
reproductive data collected by co-workers during this joint investigation 
and published elsewhere. 
The free (!NH) steroid fractions of plasma and urine were the only 
steroid fractions that were found to be useful in correlating testosterone 
metabolism with spermatozoa per ejaculate and testicular size. The failure 
to be able to correlate the other steroid fractions with reproductive 
processes in the bull during this experiment was attributed to the pre-
sence of large amounts of ionone derivatives in these fractions. These 
ionone derivatives have been shown by other workers.,after the initiation 
of this experiment,to originate from feed containing large amounts of 
carotenoid compounds. The plasma and urinary free (!NH) s teroid fractions 
were elevated during that time when s permatozoa numbers per ejaculate and 
testicular size were at a minimum. However, there was a secondary rise 
in these two fractions some 29 weeks after the cessation of tes tos t erone 
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injections. This secondary increase in steroid content in the urine and 
feces was associated with an increase of spermatozoa numbers per ejaculate 
and testicular size. In addition, there also appeared to be a seasonal 
effect on steroid metabolism and testicular function. In this respect, 
a decreased rate of steroid metabolism and decreased testicular function 
were present during and immediately following the hot, sunnner months 
while an increased steroid metabolism and increased testicular function 
were present during the cold, winter months. Al so associated with the 
winter months was a tremendous increase in plasma conjugated (!NH) steroids. 
This increase in conjugated steroids in the plasma was thought to be due 
to a competition of conjugated materials (steroids, ionone derivatives, 
and thyroxine) for a pump mechanism in the process of biliary excretion 
of these compounds. 
The plasma free (INH) steroids reached a peak during testosterone 
injections, whereas the urinary free (!NH) steroids continued to rise 
until testosterone injections were stopped. This failure to observe a 
high level of free (!NH) steroids in the plasma throughout the injection 
period was thought to be due in part to the rapid excretion of free 
stero i ds by the kidney. In this respect, a homeostatic mechanism was 
proposed whereby the steroid pump mechanism in the kidney tubule cells 
was depressed during prolonged exposure to excessive amounts of fr ee 
steroids. 
Metabolic schemes were presented to explain the apparent metabolism 
and conjugation of ionone derivatives from the feed. These s chemes ~ based 
on compounds which have been isolated from urine of cattle by other 
workers, were proposed to explain the decrease in !NH-positive chromogens 
in the feces throughout the experiment. Concomitant with this decrease 
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in !NH-positive chromogens in the feces was an increase in the 17-keto-
steroid (Zimmerman) material in the urine and feces. These schemes also 
were used to explain the lack of agreement between the 17-ketosteroid 
(Zimmerman) fraction and the 17-ketosteroid (INH) fraction in the feces . 
At the start of the experiment these two steroid fractions agreed quite 
closely but differed markedly at the end of the experiment. In this 
respect, there appeared to be an age effect on the metabolism of thes e 
ionone compounds; there was an apparent increase with age in respect t o 
the ability of the aniw~l to metabolize the ionone compounds. Concomit ant 
with this increased ability to metabolize the ionone compounds was an 
increase in the 17-ketosteroid (Zimmerman) chromogens per ml. of urine 
and per gm. of feces. Compounded with this increase was an increase in 
total daily chromogen excretion in these two fractions associated with age. 
This increase was associated with an increased size of the animals and a 
corresponding increase in the maintenance requirements since the fecal dry-
matter excreted per day increased throughout the experiment. The fecal 
route of excretion predominated during the experiment; however, the dai l y 
excretion of chromogens in the urine increased throughout the experiment 
so that the fecal:urinary ratios dropped considerably by the end of the 
experiment; this observation applied to all steroid fractions. 
In Part II of the thesis, conjugation studies were undertaken t o 
evaluate the liver and adrenal as possible sites of conjugation of steroids 
in the ruminant. Additional studies were undertaken to gain information 
concerning the nature of the glucuronosyl transfer a s e enzyme sys tem. 
Sheep had a greater abil i ty t o synthes i ze UDPGA in both the l i ver 
and adrenal glands than did the dog or r at . Likewise, sheep had a great er 
ability to synthesize glucuronide conjugates of H4E, phenolphtha lein, and 
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p-nitrophenol. Glucose was shown to be a better precursor for UDPGA in 
sheep liver homogenates than galactose. This is opposite to what has been 
reported in rat liver preparations. Ovine liver microsomal preparations 
were found to conjugate H4E and H4F with almost equal ability. The adrenal 
glands of all three species had a much lower capacity to synthesize UDPGA 
as well as to conjugate H4E. 
Negative results were found in the dog with respect to the conjuga-
tion of steroids by either the liver or the adrenal glands. The failure 
to demonstrate conjugation of H4E in this species was attributed to 
competing reactions. In this respect, it was shown that a sulfatase and 
a ~-glucuronidase were present in dog liver and adrenal preparations. The 
dog liver microsomal preparations were, however, capable of synthesizing 
conjugates of phenolphthalein and p-nitrophenol. 
Evidence was obtained which was suggestive of a complex type of 
competition when H4E was used as an inhibitor and phenolphthalein and 
p-ni-trophenol were used as substrates. An attempt was made to analyze the 
kinetics of these inhibition studies.,but failed due to other competing 
reactions taking place during the incubation of the samples. 
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Animal No. 
3 
6 
2 
4 
1 
5 
X 
Animal No. 
3 
6 
2 
4 
1 
5 
x 
APPENDIX TABLE I. PLASMA (INH) FREE STEROID CONTENT BEFORE, DURING 
AND AFTER TESTOSTERONE INJECTIONS 
1958 
4-28 5-12 5-26 6-9 6-23 7-7 7-21 
(pgm./ml.) 
0 0 0 0.52 1.54 4.89 5. 77 
0 0 0 0.93 1. 29 4.58 5.10 
0 0 0 0.10 0 2.83 9.48 
0 0 0 1.65 0.41 3.19 7.42 
0 0 0.67 0.72 1.80 5.20 6.23 
o. 77 0 0 0.10 0.36 3.19 3.76 
0.13 0 0.11 0.67 0.90 3.98 6.29 
1958 
8-18 9-1 9-15 9-29 10-13 10-27 11-10 
(µgm. /ml.) 
2.99 1.34 2.32 0.93 1.65 0 0 
3.35 2.52 3.76 1.91 2.63 0 0.46 
4.38 1.08 1.39 0.21 1.85 1. 70 0 
5.10 1.18 1.91 0.67 1.85 0 0.21 
5.72 2.32 3.55 1. 70 3.40 0.26 1.65 
4.53 2.32 4.89 1.65 8.50 0 1.44 
4.34 2.00 2.97 1.18 3.31 0.33 0.63 
8-4 
4:12 
4:94 
2.63 
2.78 
1.08 
1.18 
2.79 
11-24 
1.13 
1.65 
0.46 
3.14 
1.65 
2.11 
1.69 
.... 
0 
IJl 
APPENDIX TABLE I (Continued) 
1958 
Animal No. 12-8 12-22 1-5 
3 1.85 0 0 
6 2.88 0 0 
2 0.67 0 0 
4 3.66 0 2.47 
1 2.11 0 0 
5 2.63 0 0 
x 2.30 0 0.41 
1959· 
1-19 2-2 2-16 
(.ugm. /ml . ) 
0 0 1.24 
0 0 1.18 
0 0 1.18 
0 0 1.44 
0 0 0.93 
0 0 o. 72 
0 0 1.12 
3-2 3-30 
0.52 2.88 
1.39 3.91 
1.96 2.11 
1.18 5.56 
1. 70 5.00 
1.39 6.75 
1.36 4.37 
4-27 
5.72 
6.44 
1.39 
2.11 
2.88 
3.40 
3.66 
1--' 
0 
°' 
APPENDIX TABLE II. PLASMA (INH) STEROID-GllJCURONIDE CONTENT BEFORE, 
DURING, AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 4-28 5-12 5-26 6-9 6-23 7-7 7-21 
v.igm. /ml.) 
3 16.79 18.59 15.04 5.97 o. 77 18 .85 28.89 
6 18.13 3.09 0 3.91 6.18 43.11 47.48 
2 0 70.97 21.32 1.96 3.86 17 .61 5.34 
4 38.83 3.04 60.31 14.06 2.47 4 . 17 8.50 
1 0 8.60 0 3.60 52.02 8 .24 8.39 
5 38.52 1.34 79.26 2.06 3.76 56.91 59.64 
X 18. 71 17.60 29.34 5.26 11.51 24.82 26 . 39 
1958 
Animal No. 8-18 9-1 9-15 9-29 10-13 10-27 11-10 
(,ugm. /ml . ) 
3 65.35 33.99 37.85 
-
11.38 69.37 40.63 60.82 
6 56.86 56.97 57.32 51.50 45.16 15.76 43.26 
2 2.78 12.46 3.35 30.54 28.17 44.24 42.59 
4 72.46 47.02 48.92 63.34 60.82 9.06 59.79 
1 4 .12 44.05 52.84 56.08 50.09 77 . 10 47.48 
5 20.24 33.89 30.08 71. 69 79.31 92 . 29 88.22 
X 36.97 38.06 38.39 47.42 56.82 46.51 57.03 
8-4 
40.32 
45.78 
16.38 
43 .00 
16.94 
0 
27.07 
11-24 
49 . 65 
54 .85 
22.35 
45.58 
40.79 
26.47 
39.95 
I-' 
0 
" 
APPENDIX TABLE II (Continued) 
1958 
Animal No. 12-8 12-22 1-5 1-19 2-2 
(p.gm. /ml.) 
3 15.19 93.16 133.49 28.31 96.78 
6 12.26 77.69 120.49 37.36 95.47 
2 7.31 3.13 103.86 2.96 9.71 
4 15.76 63.74 192.75 65.18 · 136.12 
1 12.98 174.64 160.20 99.09 77 .87 
5 50.62 195.22 171.35 119 .01 135.30 
x 19.02 118.40 147.02 63.09 91.88 
1959 
2-16 3-2 
125.10 87.07 
44.77. 77 .86 
23.87 20.58 
144.35 51.85 
110.12 55.47 
169.21 154.23 
102. 91 74.51 
3-30 
53;61 
63;6o 
34;35 
49~54 
52;22 
· 9 .89 
43.87 
4-27 
1.54 
·8.60 
42.95 
45.58 
47.95 
83.58 
38.37 
..... 
0 
co 
APPENDIX TABLE III. PLASMA (INH) STEROID-SULFATE CONTENT BEFORE, 
DURING, AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 4-28 5-12 5-26 6-9 6-23 7-7 7-21 8-:,-4 
(pgm. /ml.) 
3 19~11 28.74 10.35 13.18 47.59 0.46 6.75 0'.98 
6 15:86 4.33 1.91 8.09 24~ 15 36;67 20~60 6:28 
2 2;27 122.79 15.55 5.87 25;54 3;91 6;95 0:26 
4 28~84 34.61 69.46 39;50 29~6i 2;37 2 ;06 11.43 
1 2.88 3.19 2.88 13;29 57;60 2;63 10:11 0 
5 47.38 4.38 151.43 7;72 1:98 27; 71 2L12 0 .. 
x 19.39 33.01 41.93 14.61 32.08 12.29 11.36 3.16 
1958 
Animal No. 8-18 9-1 9-15 9-29 10-13 10-27 11-10 11-24 
y.igm • /ml • ) 
3 31.26 2.68 4.89 3.96 6.13 1.80 24.10 20.75 
6 7.00 2.63 - 40.32 4.43 9.27 1.24 16.02 13.44 
2 0 1.49 0.67 0.67 4.17 7.26 21.99 2.68 
4 29.38 0.93 36.00 1.65 32.86 1. 75 17.92 15. 71 
1 1.44 4.17 21.63 11.07 6.44 39.55 16.79 26.99 
5 0.21 7.98 3.91 52.74 42.44 50.47 
* 
17.00 
x 11.38 3.31 17.90 12.42 16.89 17.01 19.36 17. 76 
* Average of five instead of six animals. .... 
0 
\.0 
APPENDIX TABLE III (Continued) 
1958 
Animal No. 12-8 12-22 1-5 
3 4.74 1.03 99.75 
6 5.30 2.21 54.98 
2 6.64 1.29 65.84 
4 36.31 2.14 115.06 
l 55.26 104.68 146.33 
5 30.13 127.40 100.57 
x 23.06 39.79 97.09 
1959 
1-19 2-2 2-16 
v.igm. /ml.) 
0 169.70 22.09 
2.96 45.26 2.21 
2.96 31.27 0.26 
12.67 63.04 34.76 
108.64 12.51 29.82 
146.33 174.64 60.56 
45.59 82. 74 24.95 
3-2 3-30 
32.50 0 
46.25 0.93 
7.00 0.52 
31.00 0 
53.87 18.85 
72.87 0 
40.58 3.38 
4-27 
0 
1.24 
1.65 
2.27 
14.37 
54.64 
12.36 
... 
I-' 
0 
APPENDIX TABLE IV. PLASMA (INH) TOTAL STEROID CONTENT BEFORE, DURING 
AND AFTER .TESTOSTERONE INJECTIONS 
1958 
Animal No . 4-28 5-12 5-26 6-9 6-23 7-7 7-21 8-4 
yigm. /ml.) 
3 35.90 47.33 25.49 19.67 49.90 24.20 41. 56 45.42 
6 33.99 7.42 1.91 12.93 31. 62 84.36 73.18 57.00 
2 2.27 193.76 36.87 7.93 29.40 24.35 21. 77 19.27 
4 67.67 37.65 129. 77 55.21 32.49 9 .73 17.98 57.21 
1 2.88 11. 79 3.55 17.61 110.42 16.07 25.33 18.02 
5 86.67 5. 72 230.69 9.88 12.10 87.81 84.52 1.18 
X 38.23 50.61 71.38 20.54 44.49 41.09 44.04 33.02 
1958 
Animal No. 8-18 9-1 9-15 9-29 10-13 10-27 11-10 11-24 
y.igm, /ml.) 
3 99.60 38.01 45.06 16.27 77 .15 42.43 84.92 71.53 
6 67.21 62.12 101.40 57.84 57.06 17.00 59.74 69.94 
2 7.16 15.03 5.41 31.42 34.19 53 . 20 64.58 25.49 
4 105 . 94 49.13 86.83 65.66 95.53 10.81 77 .92 64.43 
1 11 .28 51. 77 78.02 68.85 67.93 116.91 65.92 69.43 
5 24.98 44.19 38.88 126.08 130.25 142.76 
70~02 
45.58 
x 52.69 43.37 59.26 61.02 77 .02 63.85 59.40 
* Aver age of Five instead of six animals . ,_. 
,_. 
,_. 
APPENDIX TABLE IV (Continued) 
1958 
Animal No. 12-8 12-22 1-5 1-19 2-2 
(pgm. /ml.) 
3 21.78 94.19 233.24 28.31 266.48 
6 20.46 79.90 175.47 40.32 140.73 
2 14.62 4.42 169.70 5.92 40.98 
4 55.73 65.88 310.28 77 .85 199.16 
1 70.35 279.32 306.53 207.73 90.38 
5 83.38 323.02 271. 92 265.34 309.94 
x 44.38 158.19 244.52 108.68 174.62 
1959 
2-16 3-2 
148.43 120.09 
48.16 125.50 
25.31 29.54 
180.55 84.03 
140.87 111.04 
230.49 228.49 
128.98 116.45 
3-30 
56.49 
68.44 
36.98 
55.10 
76.07 
16.64 
51.62 
4-27 
7.26 
16.28 
45.99 
49.96 
65.20 
141.62 
54.39 
,_. 
,_. 
N 
APPENDIX TABLE V. URINE (INH) FREE STEROID CONTENT BEFORE, DURING, 
AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 3-17 4-28 6-9 7-21 9-1 10-13 11-24 1-5 
(pgm./ml .) 
3 2.21 0.75 2.07 3.94 3.54 4.64 4. 78 4.34 4.80 
6 3.14 2.38 2.58 2.52 5.57 5.42 6.24 3.33 3.89 
2 1.35 2.86 3.06 2. 71 6.46 7.64 4.15 2.80 3.57 
4 1. 79 3.89 2.97 3.61 8.49 5.53 3.47 2.73 3.81 
1 3.88 2.19 2.26 2.74 7.36 11.31 4.24 4.60 4.43 
5 2.50 2.98 3 .17 4.91 5.75 13.98 3.51 2.83 3.01 
x 2.48 2.51 2.68 3.40 6.20 8.09 4.40 3.44 3.92 
* Average of five instead of six animals. 
1959 
2-16 
3.27 
3.23 
4.44 
3.39 
6.78 
5.34 
4.41 
4-27 
5.21 
6.17 
9.26 
10. 23 
9.84 
8.14* 
I-' 
I-' 
w 
APPENDIX TABLE VI. URINE (INH) STEROID-GLUCURONIDE CONTENT BEFORE, DURING, 
AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 3-17 4-28 6-9 7-21 9-1 10-13 11-24 1-5 
(,ugm. /ml.) 
3 10.11 9.73 8.75 10.33 22.78 6.73 7.75 6.86 8.47 
6 7.55 7.47 7.28 10.65 10.57 6.46 8.78 7.45 2.70 
2 8.81 8.30 12.09 3.48 9.60 5.95 9.74 10.35 11.32 
4 9.28 6.76 10.84 7.32 9.09 5. 72 14.91 10.24 9.67 
1 9.50 5.76 11.60 6.84 10.54 5.82 10.42 8.40 8.11 
5 8.55 9.08 8.04 10.06 7.52 3.13 9.63 5.55 5.82 
x 8.97 7.85 9. 77 8.11 11.68 5.64 10.20 8.14 7.68 
* Average of five instead of six animals. 
1959 
2-16 
9.36 
15.94 
6.63 
6.18 
6.62 
6.09 
8.47 
4-27 
9.06 
7.85 
3.73 
6.76 
4.26 
6.33* 
I-' 
...... 
.i::--
APPENDIX TABLE VII. URINE (INH) STEROID-SULFATE CONTENT BEFORE, DURING, 
AND AFTER.TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 3-17 4-28 6-9 7':'21 9-1 10-13 11-24 1-5 
(pgm. /ml.) 
3 14.36 14.05 15.91 17.24 14.45 26.99 21.53 14.24 18.59 
6 13~63 18~98 10.13 1L79 14:01 14~87 7;22 11;79 1a;41 
2 14~67 14~62 12~60 8:14 4~67 11~58 rs:iJ 9;44 17 ~73 
4 13.44 14.98 12.84 11.92 20.70 27.24 18.47 18.96 19.86 
1 15.64 12.01 10.95 6.59 23.90 9.37 14.68 17.81 17 .15 
5 12.82 18.28 8.55 16.38 14.80 10.14 10.56 16.71 20.24 
X 14.09 15.49 11.83 12.11 15.29 16.70 15.10 14.82 18.67 
* Average of five instead of six animals. 
1959 
2-16 
15.87 
r.s:35 
11:2s 
18.03 
12.56 
15.23 
15.72 
4-27 
19:69 
ts~i6 
1'7: 13 
16~49 
16.71 
17 .28* 
I-' 
I-' 
VI 
APPENDIX TABLE VIII. URINE (INH) TOTAL STEROID CONTENT BEFORE, DURING 
AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 3-17 4-28 6-9 7-21 9-1 10-13 11-24 1-5 
(pgm. /ml.) 
3 26.68 24.53 26.73 31.51 40. 77 38.36 34.06 25.44 31.86 
6 24.32 28.83 19.99 24.96 30.15 26.75 22.24 22.57 25.06 
2 24.83 25.78 27.75 14.93 20.73 25.17 32.02 22.59 32.62 
4 24.51 25.63 26.65 22.85 38.28 38.49 36.85 31.93 33.34 
1 29.02 19.96 24.81 16.17 40.99 26.50 29.34 30.81 29.69 
5 23.87 30.34 19.76 31.35 28.07 27.25 23.70 25.09 29.07 
- 25.54 25.85 24.28 23.62 33.17 30.43 29.70 26.40 30.27 X 
~ . ·- -- ·-~. . ~· - .. ,. ' -
·-····· ·-·····- - . 
* Average of five instead of six animals • 
. 
1959 
2-16 
28.50 
34.52 
28.32 
27.60 
25.96 
26.66 
28.60 
4-27 
33.96 
29.78 
30.72 
33.49 
30.81 
31. 75* 
,_. 
,_. 
0\ 
APPENDIX TABLE IX. FECES (INH) FREE STEROID CONTENT BEFORE, DURING, 
AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 3-17 4-28 6-9 7-21 9-1 10-13 11.,.24 1-5 
(,ugm. /gm.) 
3 91.26 87.12 73.30 81.30 49.32 83.18 29.50 53.58 47.16 
6 148.08 98.06 88.10 136.54 87.52 40.94 92.94 43.12 
2 97.28 108.12 69.94 63.94 79.02 41.94 63.54 45.18 73.70 
4 84.56 101.22 82.78 67.68 78.04 52.58 34.62 61.36 52.38 
1 134.66 102.50 119.38 · 64.12 178.88 46.66 86.72· 69.36 55.34 
5 140.78 84.94 102. 20 70.44 100.40 84.16 53.38 85.14 44.70 
x 116.10 96.99 89.28 80.67 79.13* 66.01 51.45 67.93 52.73 
* Average of five instead of six animals. 
. 1959 
2-16 
23.48 
67.88 
50.32 
79.44 
88.40 
66.80 
62.72 
4-27 
15.88 
23.78 
5.62 
22.50 
42.02 
41.24 
25.17 
I-" 
I-" 
-...s 
APPENDIX TABLE X. FECES (INH) STEROID-GLUCURONIDE CONTENT BEFORE, 
DURING, AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 3-17 4-28 6-9 7-21 9-1 10-13 11-24 1-5 
(pgm. /gm.) 
3 73.30 49.82 68.38 49.32 14.00 46.56 6.32 45.38 14.90 
6 150.66 83.76 99.64 117. 60 43.60 17.36 58.12 42.92 
2 58.70 61.66 36.20 54.26 75.58 19.04 38.28 59.00 38.88 
4 99.26 65.32 54.96 51. 70 46.66 23.18 22.88 71.52 26.94 
1 123.90 68.38 95.70 58.12 60.78 21.80 54.36 75.48 51.80 
5 114.06 54.76 108-.04 52.20 39.46 16.38 41.74 69.08 21.12 
X 103.21 63.95 77 .15 63.87 47.30* 28.43 30.16 63.10 32.76 
* Average of five instead of six animals. 
1959 
2-16 
58.02 
19.54 
41.94 
49.82 
52.38 
50.62 
45.39 
4-27 
14.90 
42.22 
32.56 
30.28 
28.32 
42.42 
31. 78 
..... 
I-' 
00 
APPENDIX TABLE XI. FECES (!NH) STEROID-SULFATE CONTENT BEFORE, DURING, 
AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 3-17 4-28 6-9 7-21 9-1 10-13 11-24 1-5 
(}lgm. /gm.) 
3 85.84 94.52 . 58.60 59.88 26.14 25.16 29.80 60.28 11.94 
6 58.82 58.60 90.76 52.78 41.60 30.10 56.14 22.10 
2 45.88 80.80 39.86 37.78 24.28 49.82 44.60 65.42 27.32 
4 90.48 38.98 36.60 33.54 21. 70 29.60 33.06 44.50 31. 76 
1 77 .94 57.12 49.92 30.68 56.14 28.52 53.76 39.96 45. 68 · 
5 74.98 97.38 37.20 37 .10 40.74 50.42 49.42 51.80 40.06 
x 71.99 71.23 52.16 41.96 33.80* 37.52 40.12 53.02 29.81 
* Average of five instead of six animals. 
1959 
2-16 
26.84 
36.80 
57.12 
47.26 
48.44 
63.94 
46.73 
4-27 
21.80 
28.80 
53.86 
5i.68 
57.92 
56.20 
45.21 
I-' 
I-' 
\0 
APPENDIX TABLE XII. FECES (INH) TOTAL STEROID CONTENT BEFORE, DURING, 
AND AFTER TESTOSTERONE INJECTIONS 
1958 1959 
Animal No. 1~21 3-17 3-28 6-9 7-21 9-1 10..;13 11-24 1-5 2-16 
epgm. /gm.) 
3 250.40 231.46 200.28 190.50 89.46 154.90 65.62 159.24 74.00 108.34 
6 354.96 240 •. 42 278.50 306.92 172.72 88.40 207.20 108.14 124.22 
2 201.86 250.58 146.00 155.98 178.88 110.80 146.42 169.60 139.90 149.38 
4 274.30 205.52 174.34 152.92 146.40 105.36 90.56 177.38 111.08 176.52 
1 336.50 228.00 265.00 152.92 295.80 96.98 194.84 184.80 152.82 189.22 
5 329.82 237.08 247.44 159.74 180.60 150.96 i44.54 206.02 105.88 181.36 
X 291.30 232.17 218.59 186.50 160. 23* 131. 96 121. 73 184.05 115.30 154.84 
* Average of five instead of six animals. 
4-27 
52.58 
94.80 
92.04 
105.46 
128.26 
139.86 
102.16 
..... 
N 
0 
APPENDIX TABLE XIII. PLASMA (ZIMMERMAN) 17-KETOSTEROID CONTENT BEFORE, 
DURING, AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 2-24 3-17 3-31 4-14 4-28 5-12 5-26 6-9 
(pgm. /ml.) 
3 0.57 0.08 0.06 0.27 4.20 0.89 4.51 0.52 
6 0.49 0.31 0.09 0.23 0.86 1.96 0.59 0.55 
2 0.18 0.54 0.40 0.25 0.47 0.51 1.60 0.18 
4 0.14 0.09 0.16 0.01 0.48 1.02 0.83 1. 50 
1 0.16 0.88 0.05 0.30 0.43 0.77 1.25 0.99 
5 0.03 0.13 0.30 1.56 1.38 0.79 1.06 6.60 
X 0.26 0.34 0.18 0.44 1.30 0.99 1.64 1. 72 
1958 
Animal No. 7-21 8-8 8-18 9-1 9-15 9-29 10,-13 10-27 
(pgm. /ml.) 
3 0.61 0.74 0.37 0.50 0.40 0.58 0.15 0.30 
6 1.38 0.15 1.13 0.81 0.61 o. 77 0.32 0.15 
2 0.32 0.47 0.23 1.81 0.07 0 .18 0.23 0.20 
4 0.70 0.61 0.32 0.61 0.26 0.46 0.26 0.30 
1 2.01 1.13 0.37 0.18 0.34 0.23 0.20 0 .36 
5 3.21 0.26 0.48 0.34 0.18 0.43 1.21 1.61 
x 1.37 0.56 0.48 o. 71 0.31 0 .44 0.40 0.49 
6-23 
5.30 
4.66 
0.03 
3.43 
4.96 
4.37 
3.79 
11-10 . 
0.41 
0.30 
0.10 
0.36 
0.41 
0.41 
0 . 33 
7-7 
0.34 
1.85 
0.29 
0.46 
2.50 
2.37 
1. 30 
11-24 
0.48 
0.74 
0.52 
0.48 
0.98 
1.13 
0.72 
,_. 
N 
,_. 
AP,FENDIX:VTASLEX-II.I (Continued) 
1958 
Animal No. 12-8 12-22 1-5 1-19 
3 0.15 0.29 2.06 0.07 
6 0.02 0.32 0.58 0.05 
2 0.29 0.20 0.34 0.15 
4 0.07 1.60 1.42 0.34 
1 0.20 1.02 0.67 0.40 
5 0.23 0.55 2.57 0.40 
x 0.16 0.66 1.27 0.24 
.. , 1959 
2-2 2.:.16 
y.igm. /ml.) 
0.29 1.25 
0 .15 l. 70 
0.23 0.20 
0.07 0.81 
0.32 1.13 
0 .12 4.99 
0.20 1.68 
3-2 3-30 
0.34 0.26 
1. 75 3.60 
0.32 0.34 
0.07 0.52 
0.23 2.37 
1.29 6.18 
0.67 2.21 
4-27 
!L12 
3~82 
0.55 
o. 77 
0.95 
6.89 
2.52 
..... 
N 
N 
APPENDIX TABLE XIV. URINE (ZIMMERMAN) 17-KETOSTEROID CONTENT BEFORE, 
DURING, AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 2-10 2-24 3-17 3-31 4-14 4-29 5-12 5-26 6-9 
(pgm. /ml.) 
3 28.78 20.57 27.57 34.73 39.97 37.17 21.11 23.59 15.16 29.59 
6 24.94 17.95 22.33 37.17 27.97 25.67 14 .39 25.67 18.13 21.38 
2 18.45 20.03 18.26 38.52 17.46 11.37 20.03 18.94 20.66 23.46 
4 23.69 22.33 30.67 33.61 18.45 26.39 19.49 24.18 23.46 
1 31.53 31.53 27.48 19.49 21.11 15.66 18.95 17.46 33.02 19.40 
5 26.39 29.68 28.46 27.97 17.01 17.00 15.20 21.38 8.78 
-X 25.61 23.68 25.80 31.92 23.66 *21.37 19.32 *21. 03 22.09 22.68 
1958 
Animal No. 6-23 7-7 7-22 8-4 8-19 9-1 9-15 9-29 10-13 10-27 
yigm. /ml.) 
3 20.66 29.59 11.82 31.30 54.31 43.48 34.05 28.78 38.97 29.59 
6 27.97 29.59 22.01 20.03 48.54 38.97 20 .66 22.73 41.14 34.01 
2 24.90 38.97 24.90 36.90 51.33 41.14 34.91 59.36 47.18 44.66 
4 25.62 48 .54 37.89 16.89 49.89 42 .22 38 . 97 61.17 49.89 25 .62 
1 34.91 37.89 18.76 36.90 48 .54 59.36 55.93 42 . 22 35.91 34.01 
5 42.22 52.78 6.86 90.22 59.36 65.04 37 .89 43.48 34.01 29.59 
x 29.38 39.56 20.37 38.70 52.00 48.37 37.07 42.96 41.18 32.91 
* Average of five instead of six animals. ,_. 
N 
Lu 
APPENDIX TABLE XIV (Continued) 
1958 
Animal No. 11-10 11-24 12-8 12-22 
3 37.89 33.02 35.90 12.90 
6 43.48 37.89 l~5. 92 14.52 
2 37.89 37.89 38.97 33.02 
4 43.48 38.74 44.66 29.59 
1 48.54 52.78 32.12 19.40 
5 34.01 29.59 24.90 25.62 
- 40.88 38.32 37.08 22.51 X 
* Average of five instead of six animals. 
1959 
1-5 1-19 2-2 2-16 
(.ugm. /ml. ) 
38.43 28.78 36.90 l}O. 06 
30. !}0 25.62 l}O. 06 29.59 
27 .15 21.38 38.97 33.02 
37.89 30.40 35.91 30.40 
31.30 29.59 34.91 41.14 
44.66 24.18 32.12 4.5, 92 
32.97 26.66 36 ,L}8 36.69 
3-2 
47.18 
45.54 
59.36 
55.93 
51.33 
42.22 
50. 76 
3-30 
34.91 
44.66 
40.06 
43.48 
41.14 
43.48 
41.28 
4-27 
35~91 
33.02 
49.89 
57.56 
67.21 
48.72* 
1--' 
N 
+" 
APPENDIX TABLE XV. URINE (INH) 17-KETOSTEROID CONTENT BEFORE, DURING 
A~ . AFTER . TESTOSTEl,l()~~ .. I~JEC'p:QJ;iIS ... 
_,,' .... -
1958 
Animal No. 1-27 2-10 3-18 3-31 4-14 4-29 5-12 5-26 6-9 6-23 
(µgm. /ml.) 
3 8.40 6.92 9.57 10.31 12.74 8.57 . 10. 72 3.73 8.80 7.95 
6 9.20 4.78 10.67 7 .10 11.59 4.04 10.05 4.37 6.39 10.34 
2 7.13 5.81 9.67 3.52 5.27 8.12 11.42 5.91 7.17 7.87 
4 9.07 7.65 7.68 4.88 13.92 12.09 5.62 8.69 8.76 
1 10.01 8.36 5.76 4.08 15.07 6.80 9.35 8.65 5.21 10.86 
5 8.49 8.98 9.25 3.66 8 .17 7.10 4.08 10.42 10.90 
x 8. 72 7.08 8.43 5.59 .· 10.57* 8.09 10. 73* 5.39 7.78 9.45 
1958 
Animal No. 7-7 7-21 8-4 8-18 9-1 9-15 9-29 10-13 10-27 11-10 
(µgm. /ml.) 
3 10.51 4.02 4.84 14.61 10.03 8.55 9.64 9.72 11.58 7.75 
6 10.46 8.14 6.94 14.34 8.90 4.47 16.03 9.33 13.66 10.98 
2 16.03 8.32 9.17 14.05 10. 77 9.65 18.00 9.83 13.25 7.60 
4 15.66 3.77 4.88 12.20 12.38 9.83 17.18 10. 36 7.91 10.18 
1 14.54 8.03 11.12 12.50 13.51 14.50 19.34 7.58 8.73 7.68 
5 15.82 5.64 6.14 10.73 15.37 7.95 15.04 8.67 9.87 4.24 
x 13.84 6.32 7.18 13.07 11.83 9.16 15.87 9.25 10.83 8.07 
* Average of five instead of six animals. ,_.. 
N 
\J1 
APPENDIX TABLE XV.(Continued) 
1958 
Animal No. 11-24 12-8 12-22 1-5 
3 6.61 9.60 8.28 11.12 
6 9.15 11.93 6.32 12.30 
2 11.93 10.55 s:60 11. 78 
4 12.17 12.30 5.81 10. 67 
1 11.89 11.06 5.46 8.90 
5 5.79 18.31 4.08 8.98 
x 9.59 12.29 5.92 10.62 
* Average of five instead of six animals. 
1959 
1-19 2-2 2-16 
C,ugm. /ml.) 
5.91 11.93 8.47 
4:76 12:40 1:97 
7~02 10:13 1:15 
8:55 12:90 6:66 
5.91 13.31 8.90 
5.11 14.32 10.03 
6.21 12.43 8.30 
3-2 3-30 
10;84 s:63 
10:36 8:92 
10:69 tL94 
1L52 13;45 
7.99 12.07 
10.55 9.83 
10.32 10.31 
4-27 
n;31 
ro:3s 
10 :67 
rs:i4 
13. 74 
12.29* 
,,_. 
N 
°' 
APPENDIX TABLE.XVI. URINE (INH) 17-HYDROXYCORTICOSTEROID CONTENT BEFORE, 
DURING, AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 1-27 2-10 2-24 3-17 3-31 4-14 4-28 5-12 5-26 6-9 
Cugm. /ml.) 
3 1.04 0.19 1.62 0.20 0.98 0.89 0.90 0.99 0.13 0.81 
6 0.94 0.07 1.83 0.65 0.83 0.76 0.42 1.05 0.05 0~46 
2 0.54 0.16 2.44 0.46 0.31 0.50 0.72 1.04 0.16 0~23 
4 0.97 0.45 2.46 0.35 0.38 0.76 0.90 0.35 0.69 
1 0.95 0.24 1.69 0.73 0.46 0.64 0.25 1.09 0.39 0.43 
5 0.81 0.09 1.94 0.47 0.36 0.73 0.83 0.34 1.13 
X 0.88 0.20 2.00 0.48 0.66 0.70* 0.65 1.01* 0.24 0.62 
1958 
Animal No. 6-25 7-7 7-21 8-4 8-18 9-1 9-15 9-29 10-13 10-27 
(Aigm. /ml.) 
3 0.55 0.75 0.42 0.18 0.79 0.80 0.84 0.56 0.75 0.39 
6 0.68 1.05 0.32 0.32 0.88 0.78 0.58 0.72 0.57 o. 74 
2 0.66 0.90 0.23 0.42 0~28 0.68 0.75 1.24 0.63 1.23 
4 1.12 0.84 0.88 0.29 0.62 0.65 1.05 1.55 0.65 0.60 
1 0.82 0.88 0.36 0.35 0.31 0.86 o. 74 2.56 0.55 0.97 
5 0.86 1.17 0.09 0.51 0. 57 0.52 0.58 1.02 0.74 0.39 
x 0.78 0.93 0.38 0.34 o. 58 0.72 0.76 1.28 0.65 0.72 
* Average of five instead of six animals. ,... 
N 
...., 
APPENDIX TABLE XVI (Continued) 
1958 
Animal No. 11-10 11-25 12-8 12-22 
3 0.51 0.79 1.29 0.25 
6 0.82 0.97 1.45 
2 0.71 1.16 1.48 
4 1.16 1.26 0.91 0.38 
1 0.82 1.17 1.41 
5 4.68 1.71 0.65 0.13 
x 1.45 1.01 1.20 0.13 
* Average of five instead of six animals. 
1959 
1-6 2-16 3-2 
(µgm./ml.) 
0.63 3.27 0.51 
0.75 0.93 1.08 
0.97 0.36 0~ 74 
0.58 1.03 0.82 
0~55 0~53 0:55 
0.65 0.54 0.75 
0.83 1.11 0. 74 
3-30 
0.71 
0.90 
6~79 
1.05 
0;73 
0.65 
0.80 
4-27 
0.88 
1.03 
o:68 
o·; 76 
l.88 
1.05* 
·---. 
..... 
N 
00 
APPENDIX TABLE XVII. FECES (ZIMMERMAN) 17-KETOSTEROID CONTENT BEFORE, 
DURING, AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 2-24 3-18 3-31 4-14 4-28 5-12 5-26 6-9 
v.igm, /gm.) 
3 225.77 46.15 39. 77 179.31 129.84 133.17 103.20 77 .16 
6 114.32 38.09 28.67 234.16 235.17 122.28 131 .62 116. 55 
2 133.56 42.51 39.24 115.48 140.43 171. 78 92.43 62.91 
4 139.60 39.84 42.27 64.81 231.53 182.69 109.39 75.34 
1 162.30 31.86 42.76 214.72 267.02 153.82 152.69 64.48 
5 102 .19 43.10 42.82 149. 77 245.61 174.55 181.05 94.61 
X 102.21 40.26 40.92 159. 71 209.27 156.38 128. 40 81.84 
1958 
Animal No. 7-21 8-4 8-9 9-1 9-15 9-29 10-13 10-27 
v.igm, /gm.) 
3 163.14 147.20 66.02 214.13 210.64 201.15 180.48 94.47 
6 203.20 135.79 63.86 321.45 274.08 219.62 290.98 134.41 
2 179.96 181. 83 155.87 108.17 222.57 273.33 251. 76 138.55 
4 160.83 125.98 70.76 235.62 201.05 235.03 192.93 174 . 56 
1 179 .52 133 .24 45.11 215.41 195.71 230.19 212.12 280.48 
5 269.64 120.92 78.94 252.81 258.09 214.47 176.91 161.63 
- 192 .72 140.83 80.09 224.60 227.02 228.97 217.53 164.02 X 
6-25 
99.29 
112. 54 
117.15 
131. 34 
127.29 
110. 50 
116. 35 
11-10 
80.40 
88.88 
134.41 
259.83 
226.80 
256.43 
174.46 
7-7 
13. 75 
17.96 
9.18 
11.28 
19.75 
61.28 
22.20 
11-24 
51.69 
43.23 
50.64 
55.89 
47.09 
49.71 
49. 71 
1--
N 
\0 
APPENDIX TABLE XVII (Continued) 
1958 
Animal No. 12-8 12-22 1-5 
3 50.94 93.91 130.81 
6 45.54 171.14 134.98 
2 36.94 261.62 183.65 
4 44.67 403.44 313.86 
l 45.88 263.66 207.16 
5 33.45 226.79 241.83 
x 49.90 236.76 202.05 
1959 
1-19 2-2 2-16 
(µgm. /gm.) 
235.89 48.15 115.57 
298.37 107. 60 138.20 
205.69 83.27 163.46 
306.15 116.84 121.35 
202.23 120.28 253.73 
316.24 146.83 158.94 
311. 79 103.83 158.54 
3-2 
158.95 
212.54 
107. 25 
120.87 
182.07 
82.01 
143.95 
3-30 
130.55 
183.83 
172.75 
194.45 
206.74 
211.54 
183.31 
4-27 
127.75 
151.45 
130.56 
140.13 
145.35 
176.46 
145.28 
I-' 
l.,J 
0 
Animal No. 
3 
6 
2 
4 
1 
5 
x 
Animal No. 
3 
6 
2 
4 
1 
5 
X 
APPENDIX TABLE XVIII. FECES (INH) 17-KETOSTEROID CONTENT BEFORE, DURING, 
AND AFTER TESTOSTERONE INJECTIONS 
1958 
3-17 3-31 4-14 4-28 5-12 5-26 6-9 6-23 7-7 
(µgm. /gm.) 
35.41 33.90 157.42 102. 68 97.04 92.38 71.34 69.68 98.45 
39.86 30.63 213.23 180.81 150.44 105.04 40.90 71.10 118. 25 
38.07 44. 70 95.34 172. 20 114. 98 113. 72 70. 30 71.18 153.05 
40.68 46.67 110. 74 150.17 112. 60 99.59 46.46 83.70 86.87 
33.56 30.71 100.28 239.82 127.23 110 .48 38.42 58.50 109.10 
50.28 40.57 159.57 216.56 97.73 103. 34 66.20 64.84 131. 67 
39.59 37.86 139.43 177 .04 116.67 104.09 55.60 69.83 116. 23 
1958 
8-4 8-18 9-1 9-15 9-29 10-13 10-27 11-10 11-24 
vigm. /gm.) 
65.15 50.32 92.97 90.91 80.96 99.90 84.78 102.02 77 .25 
77 .38 135.59 104.06 120.70 88.12 129.74 95.40 121. 68 72. 75 
76.12 81.08 84.42 86.34 110. 51 121. 35 88.68 109.17 82.79 
53.79 63.07 93.73 94.06 94.60 106.26 97 . 44 168.31 71.87 
85.66 46.94 112.87 100.89 100.45 104.20 159.39 131.06 62.16 
78.28 81.61 101.06 89.60 99.05 97.13 114.30 159.57 84.51 
72. 73 76.44 98.18 97.03 95.62 109.76 106 .66 131. 97 75.24 
7-21 
108.92 
130 .14 
112. 00 
119 .15 
143.53 
155.82 
128.26 
12-8 
43.07 
60.57 
68.57 
81.80 
59.59 
76.45 
65.01 
I-' 
w 
I-' 
APPENDIX TABLE XVIII (Continued) 
1958 
Animal No. 12-22 1-5 1-19 2-2 
(pgm. /gm.) 
3 60.45 77 .81 61.80 82.40 
6 87.98 79.70 79.13 112. 65 
2 107.74 95.53 72.09 109. 25 
4 113 .19 105.48 92.81 81;25 
1 123.16 112.17 110.83 96.35 
5 84.00 118 .40 146.15 140.08 
X 96.09 98.18 93.80 104.66 
19-59 
2-16 3-2 3-30 
61.29 67.44 49.15 
65.45 82.95 46:06 
70.56 74.92 68.12 
74~81 74~ 10 49:47 
109~54 9'.L83 74.39 
68.82 67:27 80:38 
75.08 76.75 61.26 
"' 
''"' 
4-28 
58:42 
66;11 
51;99 
61:so 
90;24 
18: io 
68.83 
I-' 
vJ 
N 
APPENDIX TABLE XIX. FECES (!NH) 17-HYDROXYCORTICOSTEROID CONTENT 
BEFORE, DURING, AND AFTER TESTOSTERONE INJECTIONS 
1958 
Animal No. 2-24 3-17 3-31 4-14 4-28 5-12 5-26 6-9 
(,ugm./gm.) 
3 4.34 11.88 19.69 29.91 15. 72 18.02 17.37 18.98 
6 1.69 8.24 9.89 38.23 43.53 28.88 30.12 36:70 
2 4.13 13.26 19.21 16.08 29.34 18.88 20.34 12.08 
4 11.68 11.61 16.93 30.10 36.73 18.16 24.14 25.39 
1 10.88 8.52 15.76 55.42 58. 77 20.22 24.58 42.53 
5 10.31 6.89 17.56 21.98 47.26 25.73 26.79 20.26 
x 7 .17 10.07 16.51 31.95 38.56 21.65 23.89 25.99 
1958 
Animal No. 7-21 8-4 8-18 9-2 9-14 9-29 10-13 10-27 
~gm. /gm.) 
3 9.06 6.85 6.15 11.43 15.33 15.83 20. 77 6.34 
6 31.06 9.27 5.97 18.94 18.59 16.00 19 . 19 13.20 
2 23.54 5.43 12.33 11. 77 38.12 18. 60 21.59 12.51 
4 23.66 11.83 10.59 14.05 18 .59 20.02 22 . 51 14.30 
1 31.59 10.63 13.25 15.61 22.92 18.63 19.81 27 .73 
5 30.62 8 .15 12.20 13.62 29.81 17.09 13. 97 11.39 
X 24.92 8.69 10.08 14.24 23.89 17.70 19 .64 14.24 
6-23 
24.55 
30:86 
29;03 
46.02 
26.73 
22.94 
30.04 
11-10 
10. 25 
12.06 
12.73 
22.51 
23.08 
65.24 
24.31 
7-7 
14.08 
19:18 
2L51 
12.92 
18.25 
28.16 
19.02 
11-24 
8.68 
7.09 
8.26 
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11.82 
9.31 
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APPENDIX TABLE XIX (Continued) 
1958 
Animal No. 12-8 12-22 1-5 1-19 
3 7.09 5.48 12.91 6.01 
6 9.35 9.17 5.16 9.98 
2 9.47 11.51 11.20 8.87 
4 11.50 13.16 18.14 7.68 
1 14.44 20.60 18.31 21.29 
5 11.08 19.89 29.33 9.49 
X 10 • .!~9 13.30 15.84 10.55 
·1959 
2-2 2-16 
{Jlgm. /gm.) 
6.82 5.69 
8.90 7.04 
9.49 6.35 
10.41 6.68 
11.06 . 8.39 
26.32 7.94 
12.17 7.02 
3-2 3-30 
6.23 6.76 
7.28 7.28 
10.70 6.14 
6.20 6.09 
8.88 10.92 
7.76 10.70 
7.84 7.98 
4-27 
9.46 
8.37 
7.29 
7.68 
13.89 
9.53 
9.37 
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